Scientific publications

Since the foundation of Syreon Research Institute in 2008 our researchers have published several hundreds of scientific papers, especially in the fields of health economics, health policy, health technology assessment, epidemiology and public health in prestigious scientific journals. In addition to peer-reviewed articles, our colleagues edited several books, co-authored several book chapters and white papers and contributed to major international conferences.

---

2024

Ágh, T., Garuolienė, K., Granas, A. G., Gregório, J., Aksoy, N., Khanyk, N., Hadžiabdić, M. O., Kardas, P. (2024).  Identifying and presenting key country-specific indicators related to medication adherence: A comprehensive study across European countries. Frontiers in Pharmacology. Doi: 10.3389/fphar.2024.1390629 Link

Ágh, T., Hiligsmann, M. (2024). Bridging the gap: enhancing medication adherence through research and innovation. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2024.2378178 Link

Ágh, T., Hiligsmann, M., Borah, B., Beaudart, C., Turcu-Stiolica, A., Manias, E., Jakab, I., Pednekar, P., Zeber, J., Peterson, A. M. (2024). Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.10.016 Link

Aksoy, N., Ozturk, N., Agh, T., Kardas, P. (2024). Adherence to the antirheumatic drugs: a systematic review and meta-analysis. Frontiers in Medicine. Doi: 10.3389/fmed.2024.1456251 Link

Aldallal, S., Farghaly, M., Fahmy, S., Alnaqbi, K. A., Al Naeem, W., Alsaadi, M., Moukarzel, M., Fasseeh, A. N., Korra, N., Abaza, S., Kaló, Z. (2024). Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions. BMJ Open. doi:10.1136/bmjopen-2024-090344 Link

Alnaqbi, K. A., Elezbawy, B., Fasseeh, A. N., Bangash, A. R., Elshamy, A., Shendi, H., Aftab, M. I., AlMarshoodi, M., Gebran, N., AlDhaheri, N., Fahmy, S. A., Al Dallal, S., Al Naeem, W., Abaza, S., Kaló, Z. (2024). Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs. Cureus. doi:10.7759/cureus.55215 Link

Alnaqbi, K.A., Elshamy, A.M., N., Gebran, Fahmy, S., Aldallal, S., Korra, N., Fasseeh, A.N., Kaló, Z. (2024). Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates. Value in Health Regional Issues. Doi: 10.1016/j.vhri.2024.101012 Link

Al Rashdi, I., Al Balushi, S., Al Shuaili, A., Al Rashdi, S., Ibrahim Al Bulushi, N., Ibrahim Al Kindi, A., Al Salmi, Q., Al Sabti, H., Korra, N., Abaza, S., Fasseeh, A.N. and Kaló, Z. (2024). A roadmap towards implementing health technology assessment in Oman. Journal of Health Organization and Management. doi: 10.1108/JHOM-01-2024-0012 Link

Árva, D., Vokó, Z., Sápi, M., Cselkó, Zs., Rákosy, Zs. (2024). The influence of institutional characteristics on implementing school-based universal addiction prevention: a Hungarian mixed-methods nationwide study on the state of implementation, barriers, and facilitators. Frontiers in Education. doi: 10.3389/feduc.2023.1240909 Link

Avşar, T.S., Elvidge, J., Hawksworth, C., Kenny, J., Nemeth, B., Callenbach, M., Ringkvist, J., Dawoud, D. (2024). Linking reimbursement to patient benefits for advanced therapy medicinal products and other high-cost innovations: Policy recommendations for outcomes-based agreements in Europe. Value in Health. Doi: 10.1016/j.jval.2024.07.007 Link

Babarczy, B. Hajdu, A., Benko, R., Matuz, M., Papp, R., Antoniou, P., Kandelaki, K., Wong, D. L., F., Warsi, S. K. (2024). Hungarian general practice paediatricians’ antibiotic prescribing behaviour for suspected respiratory tract infections: a qualitative study. BMJ Open. doi: 10.1136/bmjopen-2023-081574 Link

Babarczy, B., Scarlett, J., Sharma, T., Gaál, P., Szécsényi-Nagy, B, Kuchenmüller, T. (2024). National strategies for knowledge translation in health policy-making: A scoping review of grey literature. Health Research and Policy Systems. doi: 10.1186/s12961-023-01089-0 Link

DiStefano, M. J., Pearson, S. D., Rind, D. M., Zemplenyi, A. (2024). How do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare to the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study. Value in Health. Doi: 10.1016/j.jval.2024.04.015 Link

DiStefano, M. J., Zemplenyi, A., McQueen, R. B. (2024). Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement. Journal of Managed Care & Specialty Pharmacy. doi:  10.18553/jmcp.2024.23255 Link

Elezbawy, B., Farghaly, M., Al Lafi, A., Gamal, M., Metni, M., Visser, W., Al-Abdulkarim, H., Hedibel, M., Fasseeh, A. N., Abaza, S., Kaló, Z. (2024). Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region. Value in Health Regional Issues. doi: 10.1016/j.vhri.2024.100987 Link

Elezbawy, B., Kaló, Z., Fasseeh, A., Inotai, A., Nemeth, B., Ágh, T. (2024). The hidden burden of atopic dermatitis in central and Eastern European Countries. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2024.2416249. Link

Elvidge, J., Hawksworth, C., Avşar, T.S., Zemplenyi, A., Chalkidou, A., Petrou, S., Petykó, Zs., Srivastava, D., Chandra, G., Delaye, J., Denniston, A., Gomes, M., Knies, S., Nousios, P., Siirtola, P., Wang, J., Dawoud, D. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI). Value in Health. doi: 10.1016/j.jval.2024.05.006. Link

Fasseeh, A.N., Korra, N., Elezbawy, B., Sedrak, A.S., Gamal, M., Eldessouki, R., Eldebeiky, M., George, M., Seyam, A., Abourawash, A., Khalifa, A. Y., Shaheen, M., Abaza, S., Kaló, Z. (2024). Framework for developing cost-effectiveness analysis threshold: the case of Egypt. Journal of the Egyptian Public Health Association. doi: 10.1186/s42506-024-00159-7 Link

Gacser, Z., Bourke, S., Hosszú, D., Daniels, S. (2024). System change in practice: A report from the EHC Think Tank workstreams on Access Equity and Future Care Pathways. The Journal of Haemophilia Practice. doi: 10.2478/jhp-2024-0017 Link

Gálffy, G., Szabó, G. T., Tamási, L., Müller, V., Moldvay, J., Sárosi, V., Kerpel-Fronius, A., Kardos, T., Csada, E., Pápai-Székely, Zs., Szász, Z., Király, Zs., Hódi, G., Kovács, Zs., Balogh, É., Kovács, K. A., Darida, M., Buga, V., Rokszin, Gy., Abonyi-Tóth, Zs., Kiss, Z., Vokó, Z., Bogos, K. (2024). Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources. Pathology and Oncology Research. doi: 10.3389/pore.2024.1611754 Link

Hedibel, M., Ghanassi, F-Z., El-Fass, K. A., Fasseeh, A. N., Abaza, S., Kaló, Z. (2024). Designing a Roadmap for Health Technology Assessment Implementation in Algeria. Cureus. Doi: 10.7759/cureus.65558 Link

Hosszú, D., Dima, A. L., Fernández, F. L., Schneider, M. P., van Dijk, L., Tóth, K., Duman M., Davis, W., Andriciuc, C., Egan, R., Vrijens, B., Kardas, P., Bitterman, N., Mucalo, I., Ghiciuc, C. M., Ágh, T. (2024). Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study. Expert Review of Pharmacoeconomics & Outcomes Research. Doi: 10.1080/14737167.2024.2373184 Link

Hosszú, D., Dima, A.L., Leiva-Fernandez, F., Voirol, M.P.S., van Dijk, L., Tóth, K., Duman, M., Davis, W., Andriciuc, C., Egan, R., Vrijens, B., Kardas, P., Bitterman, N., Mucalo, I., Agh, T. (2024). PCR13 Bridging the Gap: User Engagement in Developing and Implementing Digital Medication Adherence Technologies. Value in Health. Doi: 10.1016/j.jval.2024.03.1620 Link

Hren, R., Kranjc Brezar, S., Marhl, U., Serša, G. (2024). Laser speckle contrast imaging of perfusion in oncological clinical applications: a literature review. Radiology and Oncology. Doi: 10.2478/raon-2024-0042 Link

Hren, R., Stergar, J., Simončič, U., Serša, G., Milanič, M. (2024). Assessing Perfusion Changes in Clinical Oncology Applications Using Hyperspectral Imaging. In: Jarm, T., Šmerc, R., Mahnič-Kalamiza, S. (eds) 9th European Medical and Biological Engineering Conference. EMBEC 2024. IFMBE Proceedings, vol 112. Springer. doi: 10.1007/978-3-031-61625-9_14 Link

Inotai, A., Kaló, Z., Petykó, Z., Gyöngyösi, K., O’Keeffe, D.T., Czech, M., Ágh, T. (2024). Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases. Journal of Cardiovascular Development and Disease. doi: 10.3390/jcdd11070186 Link

Inotai, A., Nagy, D., Kaló, Z., Vokó, Z. (2024). Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000. Quality of Life Research. doi: 10.1007/s11136-024-03699-9 Link

Juhász, Á., Sebestyén, N., Árva, D., Barta, V., Pártos, K., Vokó, Z., Rákosy, Zs. (2024). We need better ways to help students avoid the harms of stress: Results of a meta-analysis on the effectiveness of school-based stress management interventions. Journal of School Psychology. doi: 10.1016/j.jsp.2024.101352 Link

Kiss, Z., Szabó, T. G., Polgár, Cs., Horváth, Zs., Nagy, P., Fábián, I., Kovács, V., Surján, Gy., Barcza, Zs., Kenessey, I., Wéber, A., Wittmann, I., Molnár, G. A., Gyöngyösi, E., Benedek, A., Karamousouli, E., Abonyi-Tóth, Zs., Bertókné Tamás, R., Fürtös, D. V., Bogos, K., Moldvay, J., Gálffy, G., Tamási, L., Müller, V., Krasznai, Z., Ostoros, Gy., Pápai-Székely, Zs., Maráz, A., Branyiczkiné Géczy, G., Hilbert, L., Berki, L.T., Rokszin, Gy., Vokó, Z. (2024). Revising Cancer Incidence In A Central European Country: A Hungarian Nationwide Study Between 2011-2019 Based On A Health Insurance Fund Database. Frontiers in Oncology. doi: 10.3389/fonc.2024.1393132 Link

Kovačević, I. N., Vujović, A., Stanišić, M., Vuković-Leković, J., Lansdorp-Vogelaar, I., Mlakar, D. N., Senore, C., Józwiak-Hagymásy, J., Széles, Gy., Vokó, Z., Csanádi, M. (2024). Roadmap to improve the organized cancer screening programs – The case of colorectal cancer screening in Montenegro. Journal of Cancer Policy. doi:10.1016/j.jcpo.2023.100464 Link

Lacosta, T.B., Inotai, A., Pereira, C. L., Barbier, L., Simoens, S. (2024). Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2024.01.018. Link

Lipska, I., Di Bidino, R., Niewada, M., Nemeth, B., Bochenek, T., Kukla, M., Więckowska, B., Sobczak, A., Iłowiecka, K., Zemplenyi, A., Martelli, N., Martin, T., Filiniuk, O., Kosyachenko, K., Sucu, R., Piniazhko, O., Zaliska, O., Avdeyev, A., Shanazarov, N., von Pinoci, M., Hren, R. (2024). Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus. Healthcare. doi: 10.3390/healthcare12090889 Link

Milanic, M., Hren, R. (2024). GPU Adding-Doubling Algorithm for Analysis of Optical Spectral Images. Algorithms. doi: 10.3390/a17020074 Link

Milanic, M., Hren, R., Stergar, J., Simoncic, U. (2024). Monitoring of Caffeine Consumption Effect on Skin Blood Properties by Diffuse Reflectance Spectroscopy. Physiological Research. doi: 10.33549/physiolres.935138 Link

Molnár, G. A., Vokó, Z., Sütő, G., Rokszin, Gy., Nagy, D., Surján, Gy., Surján, O., Nagy, P., Kenessey, I., Wéber, A., Pálosi, M., Müller, C., Kásler, M., Wittmann, I., Kiss, Z. (2024). Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study). BMJ Open Diabetes Research and Care. doi: 10.1136/bmjdrc-2023-003777 Link

Nayak, D., Borah, B., Agh, T., Pednekar, P., Unni, E., Peterson, A. (2024). PCR15 Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions. Value in Health. Doi: 10.1016/j.jval.2024.03.1622 Link

Otte, M., Dauben, H. P., Ahn, J., Gutierrez Ibarluzea, I., Drummond, M., Simoens, S., Kaló, Z., Suh, D. C. (2024). Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2024.2398482 Link

Pitter, J.G., Nagy, L., Nagy, B., Hren, R. (2024). Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of Personalized Medicine. doi: 10.3390/jpm14060599 Link

Preusser, M., Kazda, T., Le Rhun, E., Sahm, F., Smits, M., Gempt, J., Koekkoek, J. A.F., Monti, A. F., Csanadi, M., Pitter, J. Gy., Bulbek, H., Fournier, B., Quoilin, C., Gorlia, T., Weller, M., Minniti, G., on behalf of the European Organisation for Research, Treatment of Cancer (EORTC) Brain Tumor Group (2024). Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study. Trials. Doi: 10.1186/s13063-024-08213-7 Link

Rajabi, T., Szilberhorn, L., Győrbíró, D., Tatár, M., Vokó, Z., Nagy, B. (2024). Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography: Comparing Hungarian Screening Protocols with the US NLST. Cancers. doi: 10.3390/cancers16172933 Link

Simoens, S., Lacosta, T. B., Inotai, A. (2024). Learnings from cross-border biosimilar pricing policies in Europe. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2024.2334343 Link

Stergar, J., Hren, R., Milanič, M. (2024). Effects of phantom microstructure on their optical properties. Journal of Biomedical Optics. doi: 10.1117/1.JBO.29.9.093502 Link

Tachkov, K., Somolinos-Simón, F., Tapia-Galisteo, J., Hernando, M. E., García-Sáez, G., Dimitrova, M., Kamusheva, M., Mitkova, Z., Petykó, Zs., Németh, B., Kaló, Z., Tesar, T., Paveliu, M-S., Piniazhko, O., Lipska, I., Turcu-Stiolica, A., Savova, A., Manova, M., Hren, R., Došenović Bonča, P. Knies, S., Stanak, M., Doležal, T., Vitezic, D., Petrova, G. (2024). Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries. Biotechnology & Biotechnological Equipment. Doi: 10.1080/13102818.2024.2371354 Link

Tittmann, J., Ágh, T., Erdősi, D., Csanády, B., Kövér, E., Zemplényi, A., Kovács, S., Vokó, Z. (2024). Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary. Discover Oncology. doi: 10.1007/s12672-024-01096-9 Link

van Boven, J.F.M., Lavorini, F., Agh, T., Sadatsafavi, M., Patino, O., Muresan, B. (2024) Cost-effectiveness and impact on healthcare utilization of interventions to improve medication adherence and outcomes in asthma and COPD: A systematic literature review. The Journal of Allergy and Clinical Immunology: In Practice. doi: 10.1016/j.jaip.2023.12.049. Link

Wennekes, M.D., Almási, T., Eilers, R., Mezei, F., Petykó, Zs. I., Timen, A., Vokó, Z. (2024). Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review. Archives of Public Health. doi: 10.1186/s13690-024-01260-1 Link

Zelei, T., Vokó, Z., Németh, B., Petykó, Zs., Banerjee, G., Sikirica, V. (2024). Survival of Propionic Acidemia patients with liver transplant. Molecular Genetics and Metabolism Reports. doi: 10.1016/j.ymgmr.2024.101093 Link

 

2023

Ágh, T., Hiligsmann, M., Borah, B., Beaudart, C., Turcu-Stiolica, A., Manias, E., Jakab, I., Pednekar, P., Zeber, J., Peterson, A.M. (2023). A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions – An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.10.016 Link

Ágh, T., van Boven, J. F. M., Kardas, P. (2023). Europe’s cost of living crisis jeopardises medication adherence. BMJ. doi: 10.1136/bmj.p747 Link

Alamer, M., Kaló, Z., Schuller, T., Almomani, E., AlQutob, R. (2023). Understanding of the Readiness for HTA Implementation in Jordan as a Step Towards Universal Health Coverage. Jordan Medical Journal. doi: 10.35516/jmj.v57i1.1103 Link

AlRashdi, I., Albalushi, S., Alshuaili, A., AlRashdi, S., Al Bulushi, N. I., Al kindi, A. I., Korra, N., Fasseeh, A., Abaza, S., Kaló, Z. (2023). HTA355 A Roadmap Towards Implementing HTA in Oman. Value in Health. doi: 10.1016/j.jval.2023.09.2038 Link

Árva, D., Vokó, Z., Sápi, M., Cselkó, Z., Rákosy, Z. (2023). Addiction prevention & mental health support in Hungarian elementary schools: a mixed-methods study, European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1524 Link

Árva, D., Vokó, Z., Sápi, M., Cselkó, Zs., Rákosy, Zs. (2023). The Influence of Institutional Characteristics on Implementing Schoolbased Universal Addiction Prevention: A Hungarian Mixed-Methods Nationwide Study on the State of Implementation, Barriers, and Facilitators. Frontiers in Education. doi:  10.3389/feduc.2023.1240909 Link

Babarczy, B., Józwiak-Hagymásy, J., Ameyaw, D., Obeng, G. D., Zelei, T., Szeles, G., Banerjee, G., Sikirica, V. (2023). EE702 Humanistic and Economic Burden of Methylmalonic Acidemia—A Systematic Literature Review. Value in Health. doi: 10.1016/j.jval.2023.09.967 Link

Callenbach, M.H. E., Ádám, I., Vreman, R. A., Németh, B., Kaló, Z., Goettsch, W. G. (2023). Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook. Drug Discovery Today. doi: 10.1016/j.drudis.2022.103433 Link

Choon-Quinones, M., Hose, D., Kaló, Z., Zelei, T., Harousseau, J-L., Durie, B., Keown, P., Barnett, M., Jakab, I. (2023). Patient and Caregiver Experience Decision Factors in Treatment Decision Making—Results of a Systematic Literature Review of Multiple Myeloma Decision Aids. Value in Health. doi: 10.1016/j.jval.2022.04.003 Link

Choon-Quinones, M., Zelei, T., Németh, B., Tóth, M., Jia, X. Y., Barnett, M., Keown, P., Durie, B., Harousseau, J-L, Hose, D., Kaló, Z. (2023). Systematic literature review of health economic models developed for multiple myeloma to support future analyses. Journal of Medical Economics. doi: 10.1080/13696998.2022.2144056 Link

Elezbawy, B., Fasseeh, A. N., Fouly, E., Tannira, M., Dalle, H., Aderian, S., Abu Esba, L. C., Al Abdulkarim, H., Ammoury, A., Altawil, E., Al Turaiki, A., Albreiki, F., Al-Haddab, M., Al-Lafi, A., Alowayesh, M., Al-Sheikh, A., Elsayed, M., Elshamy, A., Eshmawi, M., Farag, A., Hamadah, I., Hedibel, M., Kannenberg, S., Karam, R., Metni, M., Raboobee, N., Steinhoff, M., Abaza, S., Farghaly, M., Kaló, Z. (2023).  Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region. Dermatology and Therapy. doi: 10.1007/s13555-022-00857-0 Link

Elvidge, J., Summerfield, A., Knies, S., Németh, B., Kaló, Z., Goettsch, W., Dawoud, D. (2023). Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International Journal of Technology Assessment in Health Care. doi:10.1017/S0266462323000223 Link

Fasseeh, A.N., Elezbawy, B., El-Fass, K.A., GamaI, M., Seyam, A., Hayek, N., Rahman, N.A., Abdelhamid, S., Fasseeh, N., Saad, A.S., Elagamy, A., Mahmoud, A., Sedrak, A.S., Elshazly, K., Eldebeiky, M., Talaat, M., Mohamed, N.M., Abdelaziz, R.A., Refaat, R., Akeel, S., Abaza, S., Kaló, Z. (2023). Maximizing the benefits of using biosimilars in Egypt. Journal of Pharmaceutical Policy and Practice. doi: 10.1186/s40545-023-00581-w Link

Fasseeh, A., Salem, A. A., Rasmy, A .M., El Gendy, H. , Szilberhorn, L., Barakat, T., Radwan, M., Nagy, B. (2023). Cost-Effectiveness Analysis of Ceftazidime/Avibactam Versus Polymyxin E in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: Literature Review. The Egyptian Journal of Hospital Medicine. doi: 10.21608/ejhm.2023.287325 Link

Hawksworth, C., Elvidge, J., Knies, S., Zemplenyi, A., Petykó, Zs. I., Siirtola, P., Chandra, G., Srivastava, D., Denniston, A., Chalkidou, A., Delaye, J., Nousios, P., Gomes, M., Saygın Avşar, T., Wang, J., Petrou, S., Dawoud, D. (2023). Protocol for the development of an artificial intelligence extension to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022. doi: 10.1101/2023.05.31.23290788. Link

Huygens, S., Vellekoop, H., Versteegh, M., Santi, I., Szilberhorn, L., Zelei, T., Nagy, B., Tsiachristas, A., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2023). Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib. Value in Health. doi: 10.1016/j.jval.2022.08.006 Link

Hren, R., Sersa, G., Simoncic, U., Milanic, M. (2023). Imaging microvascular changes in nonocular oncological clinical applications by optical coherence tomography angiography: a literature review. Radiology and Oncology. doi: 10.2478/raon-2023-0057 Link

Ispán, F., Hegedüs, T., Csanádi, M., Nagy, B. (2023). A kockázatmegosztási megállapodások adminisztrációs terhei Magyarországon – Irány az automatizáció? - Administrative burden of managed entry agreements for pharmaceuticals in Hungary – towards automation?. IME. doi: 10.53020/IME-2023-407 Link

Jakab, I., Dimitrova, M., Houÿez, F., Bereczky, T., Fövényes, M., Maravic, Z., Belina, I., Andriciuc, C., Tóth, K., Piniazhko, O., Hren, R., Gutierrez-Ibarluzea, I., Czech, M., Tesar, T., Niewada, M., Lorenzovici, L., Kamusheva, M., Manova, M., Savova, A., Mitkova, Z., Tachkov, K., Németh, B., Petykó, Zs. I., Dawoud, D., Delnoij, D., Knies, S., Goettsch, W., Kaló, Z. (2023). Recommendations for patient involvement in health technology assessment in Central and Eastern European countries. Frontiers in Public Health. doi: 10.3389/fpubh.2023.1176200 Link

Kaló, Z., Niewada, M., Bereczky, T., Goettsch, W., Vreman, R. A., Xoxi, E., Trusheim, M., Callenbach, M. H. E., Nagy, L., Simoens, S. (2023) Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2023.2282680 Link

Kárász, D., Erdősi D., Kardas, P., Lewek, P., Klimczak, P., Łojewska, E., Kovács, S., Zemplényi, A., Agh, T. (2023). MT34 Adaptation and Cost-Effectiveness Analysis of the "My Health Everyday” Medication Adherence Coaching Application for Hypertension Management in Hungary. Value in Health. doi: 10.1016/j.jval.2023.09.2263 Link

Kardas, P., Aarnio, E., Agh, T., van Boven, J. F. M., Dima, A. L., Ghiciuc, C. M., Kamberi, F., Petrova, G. I., Nabergoj, M. U., Trečiokienė, I. (2023). New terminology of medication adherence enabling and supporting activities: ENABLE terminology. Frontiers in Pharmacology. doi:10.3389/fphar.2023.1254291 Link

Kiss, Z., Gálffy. G., Müller, V., Moldvay, J., Sarosi, V., Pápai-Székely, Zs., Csada, E., Kerpel-Fronius, A., Király, Zs., Szász, Z., Hódi, G., Polányi, Z., Kovacs, K. A., Karamousouli, E., Knollmajer, K., Szabó, T. G., Berta, A., Vokó, Z., Rokszin, Gy., Abonyi-Tóth, Zs., Barcza, Zs., Tamási, L., Bogos, K. (2023). Significant Changes In Advanced Lung Cancer Survival During The Past Decade In Hungary: Impact Of Modern Immunotherapy and the Covid-19 Pandemic. Frontiers in Oncology. doi: 10.3389/fonc.2023.1207295 Link

Koleva-Kolarova, R., Szilberhorn, L., Zelei, T., Vellekoop, H., Nagy, B., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Wordsworth, S., Tsiachristas, A. (2023). Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Personalized Medicine. doi: 10.2217/pme-2022-0145. Link

Koleva-Kolarova, R., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2023). Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized Medicine. doi: 10.2217/pme-2022-0133 Link

Koleva-Kolarova, R., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2023). Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK. Personalized Medicine. doi: 10.2217/pme-2022-0099 Link

Kovács, G., Abonyi-Tóth, Z., Fadgyas-Freyler, P., Kaló, Z. (2023). Incremental cost of premature birth - a public health care payer perspective from Hungary. BMC Health Services Research. doi: 10.1186/s12913-023-09697-w Link

Kovács, G., Mohos, E., Kis, J. T., Tabák, Á., Gerendy, P., Dózsa, Cs., Dózsa, K., Pettkó, J., Ujhelyi, K., Kaló, Z. (2023). A bariátriai műtétek egészségpolitikai szerepe a 2-es típusú cukorbetegségben szenvedő elhízott betegek ellátásában. IME Innováció, Menedzsment, Egészségügy. doi: 10.53020/IME-2023-302 Link

Kovács, G., Mohos, E., Kis, J. T., Tabák, Á., Gerendy, P., Pettkó, J., Nagy, D., Győrbíró, D., Kaló, Z. (2023). Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes. Journal of Diabetes Research. doi: 10.1155/2023/9686729 Link

Kovács, G., Nagy, D., Szilberhorn, L., Zelei, T., Gaál, Zs., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Koleva-Kolarova, R., Tsiachristas, A., Wordsworth, S., Nagy, B. (2023). Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young. Personalized Medicine. doi: 10.2217/pme-2023-0023 Link

Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S. Gasparik, A. I., Precup, A. M., Nagy, A. Gy., Niemann, C. U., Aittokallio, T., Kaló, Z., Csanádi, M. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. doi: 10.1007/s40259-023-00583-9 Link

McQueen, R.B., Inotai, A., Zemplenyi, A., Mendola, N., Németh, B., Kalo, Z. (2023). Multi-Stakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions. Value in Health. doi:10.1016/j.jval.2023.09.2910 Link

McQueen, R.B., Mendola, N.D., Jakab, I., Bennett, J., Nair, K.V., Németh, B., Inotai, A., Kaló, Z. (2023). Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods. PharmacoEconomics Open. doi: 10.1007/s41669-022-00376-w Link

Mészáros, A., Vokó, Z. (2023). Encouraging the planetary health diet via food taxes and subsidies: a model concept. European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1069 Link

Moorkens, E., Lacosta, T. B., Dawoud, D., Inotai, A., Janodia, M., Tan, C. J., Lim, K. K., Khatri, N., Pereira, C. L., Simoens, S. (2023). A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.04.007 Link

Mosli, M., Almutairdi, A., Abdulrahman, A.K., Fasseeh, A. N., Abd-El Aziz, A., Jaheen, A., Anwar, A., Elezbawy, B., Alharbi, B., Al Tawil, E., Al-Abdulkarim, H., Alqasim, H., Eldeeb, I., Ahmed El-Fass, K., Alanizy, L., Tannira, M., Almehizia, R., Abaza, S., Iskandarani, W., Kaló, Z. (2023). EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia. Value in Health. doi: 10.1016/j.jval.2023.09.595 Link

Nagy, B., Győrbíró, D., Csanádi, M. (2023). A kis dózisú komputertomográfiával történő tüdőrákszűrés hazai bevezetésének kérdései. LEGE ARTIS MEDICINAE. doi: 10.33616/lam.33.0105 Link

Nagy, B., Szilberhorn, L., Győrbíró, D.M., Moizs, M., Bajzik, G., Kerpel-Fronius, A., Vokó, Z. (2023). Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary. Value in Health Regional Issues. doi: 10.1016/j.vhri.2022.10.002 Link

Nagy, B., Zelei, T., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., R., Koleva-Kolarova, Tsiachristas, A., Wordsworth, S., Szilberhorn, L. (2023). Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies. Personalized Medicine. doi: 10.2217/pme-2023-0040 Link

Németh, B., Kamusheva, M., Mitkova, Z., Petykó, Zs. I., Zemplényi, A., Dimitrova, M., Tachkov, K., Balkányi, L., Czech, M., Dawoud, D., Goettsch, W., Hren, R., Knies, S., Lorenzovici, L., Maravic, Z., Piniazhko, O., Zerovnik, S., Kaló, Z. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. doi: 10.57264/cer-2022-0157 Link

Németh, G., Mágó, M.L., Kaló, Z., Lám, J., Balogh, T., Brodszky, V. (2023). A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply. Frontiers in Medicine. doi: 10.3389/fmed.2023.1282698 Link

Pham, T. H., Beck, E., Postma, M. J., Németh, B., Ágh, T., de Waure, C., Salisbury, D.M., Nutma, N., van der Schans, J. (2023). Country score tool to assess readiness and guide evidence generation of immunization programs in ageing adults in Europe. Frontiers in Public Health. doi: 10.3389/fpubh.2022.1080678 Link

Pitter, J.G., Zemplényi, A., Babarczy, B., Németh, B., Kaló, Z., Vokó, Z. (2023). Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe. GeroScience. doi: 10.1007/s11357-023-00975-3 Link

Rutten-van Mölken, M., Versteegh, M., Nagy, B., Wordsworth, S. (2023). HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead. Personalized Medicine. doi: 10.2217/pme-2022-0074 Link

Sayour, N. V., Brenner, G. B., Makkos, A., Kiss, B., Kovácsházi, Cs., Gergely, T. G., Aukrust, S. G., Tian, H., Zenkl, V., Gömöri, K., Szabados, T.,  Bencsik, P., Heinen, A., Schulz, R., Baxter, G. F., Zuurbier, C. J., Vokó, Z., Ferdinandy, P., Giricz, Z. (2023). Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study. Cardiovascular Research. doi: 10.1093/cvr/cvad024 Link

Staniszewska, S., Jakab, I., Low, E., Mossman, J., Posner, P., Husereau, D., Stephens, R., Drummond, M. (2023). Commentary: Advocating for patient and public involvement and engagement in health economic evaluation. Research Involvement and Engagement. doi: 10.1186/s40900-023-00444-3 Link

Szekanecz, Z., Vokó, Z., Surján, O., Rákóczi, É., Szamosi, S., Szűcs, G., Szekanecz, É., Müller, C., Kiss, Z. (2023). Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals. Frontiers in Immunology. doi: 10.3389/fimmu.2023.1247129 Link

Szilberhorn, L., Zelei, T., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Koleva-Kolarova, R., Tsiachristas, A., Wordsworth, S., Nagy, B. (2023). Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries. Personalized Medicine. Doi: 10.2217/pme-2023-0017 Link

Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Kallai,  Á. (2023). Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting. Frontiers in Public Health. doi: 10.3389/fpubh.2022.1071317 Link

Vellekoop, H., Huygens, S., Versteegh, M., Szilberhorn, L., Zelei, T., Nagy, B., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2023). Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries. Personalized Medicine. doi: 10.2217/pme-2022-0070 Link

Wennekes, M.D., Eilers, R., Caputo, A., Gagneaux-Brunon, A., Gavioli, R., Nicoli, F., Vokó, Z., Timen, A. (2023). Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries. GeroScience. doi: 10.1007/s11357-022-00682-5 Link

Wennekes, M.D., Eilers, R., Stein, M.L., Caputo, A., Gagneux-Brunon, A., Gavioli, R., Nicoli, F., Biesheuvel, J., Vokó, Z., Timen, A. (2023). Information networks of healthcare professionals in Europe on older adult vaccines: Network analysis. European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1481 Link

Zelei, T., Kovács, S., Finn, P., Nagy, D., Sikirica, V., Carlson, K. B., Vokó, Z. (2023). Systematic literature review of the epidemiology of glycogen storage disease type 1a. Journal of Pediatric Endocrinology and Metabolism. doi: 10.1515/jpem-2023-0127 Link

Zemplényi, A., Tachkov, K., Balkanyi, L., Németh, B., Petykó, Zs. I., Petrova, G., Czech, M., Dawoud, D., Goettsch, W., Gutierrez, I. I., Hren, R., Knies, S., Lorenzovici, L., Maravic, Z., Piniazhko, O., Savova, A., Manova, M., Tesar, T., Zerovnik, S., Kaló, Z. (2023). Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Frontiers in Public Health. doi: 10.3389/fpubh.2023.1088121 Link

Zielonke, N., Senore, C., Ponti, A., Csanádi, M., de Koning, H. J., Heijnsdijk, E. A. M., van Ravesteyn, N. T. (2023). Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. Journal of Medical Screening. doi:10.1177/09691413231153568 Link

 

2022

Ádám, I., Callenbach, M., Németh, B., Vreman, R.A., Tollin, C., Pontén, J., Dawoud, D., Elvidge, J., Crabb, N., van Waalwijk van Doorn-Khosrovani, S.B., Pisters-van Roy, A., Vincziczki, Á., Almomani, E., Vajagic, M., Oner, Z.G., Matni, M., Fürst, J., Kahveci, R., Goettsch, W.G., Kaló, Z. (2022). Outcome-based reimbursement in Central-Eastern Europe and Middle-East. Frontiers in Medicine. doi: 10.3389/fmed.2022.940886 Link

Ádám, I., Callenbach, M., Németh, B., Vreman, R. A., Pontén, J., Strbad, T., Dawoud, D., Kostyuk, A., Seyam, A., Nagy, L., Goettsch, W. G., Kaló, Z. (2022). Delayed payment schemes in Central-Eastern Europe and Middle-East. Frontiers in Medicine. doi: 10.3389/fmed.2022.940371 Link

Ágh, T., Hadžiabdić, M. O., Garuoliene K., Granas, A.G., Aarnio, E., Menditto, E., Gregório J., Barnestein-Fonseca, P., Mevsim, V., Kardas, P.,  European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE). (2022). Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.892240 Link

Ágh, T., Szilberhorn, L., Csanádi, M., Széles, G., Vokó, Z., Ádám, G., Kallai, Á. (2022). A kis sugárdózisú komputertomográfia szerepe a tüdőrákszűrésben. Orvosi Hetilap. doi: 10.1556/650.2022.32583 Link

Ágh, T., van Boven, J. F. M., Wettermark, B., Menditto, E., Pinnock, H., Tsiligianni, I., Kardas, P. (2022). Medication Management Practices for Noncommunicable Diseases During the COVID-19 Pandemic: A Snapshot of the European Situation. Value & Outcomes Spotlight. Link

Almomani, E., Hammad, E. A., AlQutob, R., Hammour, K. A., Al-Sharu, E., Abu-Shaer, M., Alabbadi, I., Kaló, Z. (2022). Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions. Value in Health Regional Issues. doi: 10.1016/j.vhri.2022.07.006 Link

Choon-Quinones, M., Zelei, T., Barnett, M., Keown, P., Durie, B., Kaló, Z., Almási, T., Harousseau, J.L., Hose, D. (2022). Beyond medicines' barriers: exploring the true cost of multiple myeloma. Journal of Medical Economics. doi: 10.1080/13696998.2022.2133823 Link

Csanádi, M., Ágh, T., Tordai, A., Tapprich, C., Vokó, Z., Stamatopoulos, K. (2022). Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review. Expert Review of Hematology. doi: 10.1080/17474086.2022.2042246 Link

Csanádi, M., Kaló, Z., Rutten-van Molken, M., Looman, W., Huic, M., Ercevic, D., Atanasijevic, D., Lorenzovici, L., Petryszyn, P., Pogány, G., Pitter, J., Zemplényi, A. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy. doi: 10.1016/j.healthpol.2022.08.012. Link

Dimitrova, M., Jakab, I., Mitkova, Z., Kamusheva, M., Tachkov, K., Németh, B., Zemplényi, A., Dawoud, D., Delnoij, D. M. J., Houýez, F., Kaló, Z. (2022). Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries. Frontiers in Public Health. doi: 10.3389/fpubh.2022.922708 Link

Drummond, M., Federici, C., Reckers-Droog, V., Torbica, A., Blankart, C.R., Ciani, O., Kaló, Z., Kovács, S., Brouwer, W. (2022). Coverage with evidence development for medical devices in Europe: Can practice meet theory? Health Economics. doi:10.1002/hec.4478 Link

Elek, P., Csanádi, M., Fadgyas-Freyler, P., Gervai, N., Oross-Bécsi, R., Szécsényi-Nagy, B., Tatár, M., Váradi, B., Zemplényi, A. (2022). Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models. BMJ Open. doi: 10.1136/bmjopen-2022-061941 Link

Elek, P., Fadgyas-Freyler, P., Váradi, B., Mayer, B., Zemplényi, A., Csanádi, M. (2022). Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. doi: 10.1016/j.healthpol.2022.05.013 Link

Elezbawy, B., Fasseeh, A. N., Fouly, E., Abu Esba, L. C., Al Abdulkarim, H., Al-Haddab, M., Al-Sheikh, A., Altawil, E., Al Turaiki, A., Eshmawi, M., Hamadah, I., Tannira, M., Dalle, H., Aderian, S., Roshdy, A., Jaheen, A., Hamad, T., Abaza, S., Kaló, Z. (2022). The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia. Journal of Medical Economics. doi: 10.1080/13696998.2022.2152234 Link

Elezbawy, B., Fasseeh, A. N., Németh, B., Gamal, M., Eldebeiky, M., Refaat, R., Taha, A., Rabiea, S., Abdallah, M., Ramadan, S., Noaman, H., Eldin, A. B., Mostafa, H., Nouh, S., Zaki, A., Abdelrahman, M., Abaza, S., Kaló, Z. (2022). A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt. BMC Medical Informatics and Decision Making. doi: 10.1186/s12911-022-02025-y Link

Elezbawy, B., Fasseeh, A.N., Sedrak, A., Eldessouki, R., Gamal, M., Eldebeiky, M., Amer, H., Akeel, S., Morsy, A., Amin, A., Shafik, A., Abaza, S., Kaló, Z. (2022). A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt. Journal of Pharmaceutical Policy and Practice. doi:10.1186/s40545-022-00414-2 Link

Farkas-Ráduly, Sz., Csanádi, M., Ágh, T., Szász, O.,Vokó, Z., Széles, Gy. (2022). A digitális technológia kínálta új lehetőségek a melanoma malignum szűrésében. Szakirodalmi áttekintés [New opportunities offered by digital technology in melanoma malignum screening.]. Orvosi Hetilap. doi: 10.1556/650.2022.32613 Link

Fasseeh, A. N., Elezbawy, B., Adly, W., ElShahawy, R., George, M., Abaza, S., ElShalakani, A., Kaló, Z. (2022). Healthcare financing in Egypt: a systematic literature review. Journal of the Egyptian Public Health Association. doi: 10.1186/s42506-021-00089-8 Link

Fasseeh, A. N., Elezbawy, B., Gamal, M., Seyam, A., Abourawash, A., George, M., Anwar, M., Amin, M., Khalifa, A. Y., Elshalakani, A., Hatem, A., Abdelhamid, S., Elsamouly, H., Fasseeh, N., Adel, R., Dawood, H., Abaza, S., Kaló, Z. (2022). A roadmap toward implementing health technology assessment in Egypt. Frontiers in Public Health. doi: 10.3389/fpubh.2022.896175 Link

Fasseeh, A.N., Elezbawy, B., Korra, N., Tannira, M., Dalle, H., Aderian, S., Abaza, S., Kaló, Z. (2022). Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review. Dermatology and Therapy. doi: 10.1007/s13555-022-00819-6 Link

Fasseeh, A. N., Saragih, S. M., Hayek, N., Brodovska, S., Ismail, ElShalakani, A. A., Abaza, S., Obeng, G. D., Ameyaw, D., Kalo, Z. (2022). Impact of Health Technology Assessment Implementation with Special Focus on Middle-Income Countries. Health Policy and Technology. doi: 10.1016/j.hlpt.2022.100688 Link

Gervai, N., Szécsényi-Nagy, B., Zemplényi, A., Csanádi, M., Kollányi, Zs. (2022). A társadalom járványkezelési intézkedésekkel kapcsolatos adherenciájának rendszerszemléletű vizsgálata (Adherence towards public health interventions during the COVID-19 pandemic - lessons from system dynamics). Népegészségügy. Link

Incze, A., Kaló, Z., Espín, J., Kiss, É., Kessabi, S., Garrison, L.P. (2022). Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.815029 Link

Kamusheva, M., Németh, B., Zemplényi, A., Kaló, Z., Elvidge, J., Dimitrova, M., Pontén, J., Tachkov, K., Mitkova, Z. (2022). Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2022-0065 Link

Kardas, P., Bago, M., Barnestein-Fonseca, P., Garuolienė, K., Granas, A. G., Gregório, J., Hadžiabdić, M. O., Kostalova, B., Leiva-Fernández, F., Lewek, P., Mala-Ladova, K., Schneider, M. P., van Boven, J. F. M., Volmer, D., Ziampara, I., Ágh, T. (2022). Reimbursed medication adherence enhancing interventions in 12 European countries: Current state of the art and future challenges. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.944829 Link

Khanyk, N., Hromovyk, B., Levytska, O., Agh, T., Wettermark, B., Kardas, P. (2022). The impact of the war on maintenance of long-term therapies in Ukraine. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.1024046 Link

Kiss, Z., Wittmann, I., Polivka, L., Surján, Gy., Surján, O., Barcza, Zs., Molnár, G. A., Nagy, D., Müller, V., Bogos, K., Nagy, P., Kenessey, I., Wéber, A., Pálosi, M., Szlávik, J., Schaff, Zs., Szekanecz, Z., Müller, C., Kásler, M., Vokó, Z. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. doi: 10.3389/fimmu.2022.905585 Link

Koleva-Kolarova, R., Buchanan, J., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2022). Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. Applied Health Economics and Health Policy. doi: 10.1007/s40258-021-00714-9 Link

Kovács, S., Kaló, Z., Daubner-Bendes, R., Kolasa, K., Hren, R., Tesar, T., Reckers-Droog, V., Brouwer, W., Federici, C., Drummond, M., Zemplényi, A. T. (2022). Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries. Health Economics doi: 10.1002/hec.4504 Link

Kovács, S., Németh, B., Erdősi, D., Brodszky, V., Boncz, I., Kaló, Z. and Zemplényi, A., (2022). Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?. Applied Health Economics and Health Policy. doi:10.1007/s40258-021-00710-z Link

Lorenzovici, L., Bârzan-Székely, A., Farkas-Ráduly, Sz., Pana, B.C., Csanádi, M., Chiriac, N.D., Kaló, Z. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. doi: 10.3390/healthcare10010107 Link

Main, B., Csanádi, M., Ozieranski, P. (2022). Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals. Health Economics, Policy & Law. doi: 10.1017/S1744133122000068 Link

Mayer, B., Tóth, M., Csanádi, M., Zemplényi, A., Fadgyas-Freyler, P., Oross-Bécsi, R., Elek, P., Szécsényi-Nagy, B. (2022). A COVID-19 világjárvány hatása a daganatos betegek ellátására (The impact of the COVID-19 pandemic on cancer care). Népegészségügy. Link

Németh, B., Csanádi, M., Inotai, A., Ameyaw, D., Kaló, Z. (‎2022)‎. Access to high-priced medicines in lower-income countries in the WHO European Region. World Health Organization. Regional Office for Europe. License: CC BY-NC-SA 3.0 IGO Link

Pitter, J. G., Moizs, M., Somogyiné Ezer, É., Lukács, G., Szigeti, A., Repa, I., Csanádi, M., Rutten-van Mölken, M. P. M. H., Islam, K., Kaló, Z., Vokó, Z. (2022). Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control. PLOS ONE. doi: 10.1371/journal.pone.0276719 Link

Sinkovits, B., Kovács-Borbás, V., Lovas, K., Merész, G., Rózsa, P., Salfer, B., & Kaló, Z. (2022). A társadalombiztosítási támogatásra irányuló kérelmek egészség-gazdaságtani elemzéseinek transzparenciakódexe. Lege Artis Medicinae. doi: 10.33616/lam.32.025 Link

Tachkov, K.T., Zemplényi, A., Kamusheva, M.S., Dimitrova, M.J., Siirtola, P., Pontén, J., Nemeth, B., Kaló, Z. and Petrova, G.I. (2022). Barriers to use Artificial Intelligence methodologies in Health Technology Assessment in Central and East European countries. Frontiers in Public Health. doi: 10.3389/fpubh.2022.921226 Link

Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Ormándi, K., Kallai, Á. (2022). Az automatizált emlőultrahang-daganatszűrés szakirodalmi áttekintése. Orvosi Hetilap. doi: 10.1556/650.2022.32565 Link

Vellekoop, H., Versteegh, M., Huygens, S., Ramos, I. C., Szilberhorn, L., Zelei, T., Nagy, B.,Tsiachristas, A., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2022). The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis. Value in Health. doi: 10.1016/j.jval.2022.01.006 Link

Vokó, Z., Kiss, Z., Surján, Gy., Surján, O., Barcza, Zs., Wittmann, I., Molnár, G. A., Nagy, D., Müller, V., Bogos, K., Nagy, P., Kenessey, I., Wéber, A., Polivka, L., Pálosi, M., Szlávik, J., Rokszin, Gy., Müller, C., Szekanecz, Z., Kásler, M. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. doi: 10.3389/fimmu.2022.919408 Link

 

2021

Aboulghate, M.,  Elaghoury, A., Elebrashy, I., Elkafrawy, N., Elshishiney, G., Abul-Magd, E., Bassiouny, E., Toaima, D., Elezbawy, B., Fasseeh, A., Abaza, S., Vokó, Z. (2021). The Burden of Obesity in Egypt. Frontiers In Public Health. doi: 10.3389/fpubh.2021.718978 Link

Ádám, I., Kaló, Z. (2021). Development of public financing initiatives in pharmaceutical R&D – is it the key to the future of medicine? Kaleidoscope. doi: 10.17107/KH.2021.22.316-324 Link

Agh, T., van Boven, J.F.M., Wettermark, B., Menditto, E., Pinnock, H., Tsiligianni, I., Petrova, G., Potocnjak, I., Kamberi, F., Kardas, P. (2021). A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic. Frontiers in Pharmacology I Drugs Outcomes Research and Policies. doi: 10.3389/fphar.2021685696 Link

Almomani, E., Alabbadi, I., Fasseeh, A., Al-Qutob, R., Al-Sharu, E., Hayek, N., Tarawneh, M.R., Kaló, Z. (2021). Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan. Value in Health Regional Issues. doi: 10.1016/j.vhri.2021.01.003 Link

Babela, R., Orsagh, A., Ricova, J., Lansdorp-Vogelaar, I., Csanádi, M., De Koning, H., Reckova, M. (2021). Cost-effectiveness of colorectal cancer screening in Slovakia. European Journal of Cancer Prevention. doi: 10.1097/CEJ.0000000000000727 Link

Blankart, C. R., Dams, F., Penton, H., Kaló, Z., Zemplényi, A., Shatrov, K., Iskandar, R., Federici, C. (2021). Regulatory and HTA early dialogues in medical devices. Health Policy. doi: 10.1016/j.healthpol.2021.07.010 Link

Ciani, O., Grigore, B., Blommestein, H., de Groot, S., Möllenkamp, M., Rabbe, S., Daubner-Bendes, R., Taylor, R. S. (2021). Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Agencies. Medical Decision Making. doi: 10.1177/0272989X21994553 Link

Daubner-Bendes, R., Kovács, S., Niewada, M., Huic, M., Drummond, M., Ciani, O., Blankart, C.R., Mandrik, O., Torbica, A., Yfantopoulos, J., Petrova, G., Holownia-Voloskova, M., Taylor, R.S., Al, M., Piniazhko, O., Lorenzovici, L., Tarricone, R., Zemplényi, A., Kaló, Z. (2021). Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges. Frontiers in Public Health 8:612410. doi: 10.3389/fpubh.2020.612410 Link

Elvidge, J., Summerfield, A., Knies, S., Németh, B., Kaló, Z., Goettsch, W., Dawoud, D. (2021). Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19. doi: 10.5281/zenodo.5530468 Link

Farghaly, M. N., Al Dallal, S., Fasseeh, A. N., Monsef, N. A., Suliman, E. A. M. A., Tahoun, M. A., Abaza, S., Kaló, Z. (2021). Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.680737 Link

Federici, C., Reckers-Droog, V., Ciani, O. Dams, F., Grigore, B., Kaló, Z., Kovács, S., Shatrov, K., Brouwer, W., Drummond, M. (2021). Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges. The European Journal of Health Economics. doi: 10.1007/s10198-021-01334-9 Link

Gálffy, G., Vastag, A., Bogos, K., Kiss, Z., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Knollmajer, K., Várnai, M., Szegner, P., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Pozsgai, É., Barcza, Z., Moldvay, J., Tamási. L. (2021). Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016. Pathology and Oncology Research. doi: 10.3389/pore.2021.1609916 Link

Gini, A., Buskermolen, M., Senore, C., Anttila, A., Novak Mlakar, D., Veerus, P., Csanádi, M., Jansen, E. E. L., Zielonke, N., Heinävaara, S., Széles, G., Segnan, N., de Koning, H. J., & Lansdorp-Vogelaar, I. (2021). Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe. MDM Policy & Practice. doi:10.1177/2381468320984974 Link

Gini, A., van Ravesteyn, N. T., Jansen, E. E. L., Heijnsdijk, E. A. M., Senore, C., Anttila, A., Mlakar, D. N., Veerus, P., Csanádi, M., Zielonke, N., Heinävaara, S., Széles, Gy., Segnan, N., de Koning, H. J., Lansdorp-Vogelaar, I. (2021). The EU-TOPIA Evaluation Tool: An Online Modelling--Based Tool for Informing Breast, Cervical, and Colorectal Cancer Screening Decisions in Europe. Preventive Medicine Reports. doi: 10.1016/j.pmedr.2021.101392 Link

Godman, B., Wladysiuk, M., McTaggart, S., Kurdi, A., Allocati, E., Jakovljevic, M., Kalemeera, F., Hoxha, I., Nachtnebel, A., Sauermann, R., Hinteregger, M., Marković-Peković, V., Tubic, B., Petrova, G., Tachkov, K., Slabý, J., Nejezchlebova, R., Krulichová, I. S. , Laius, O., Selke, G., Langner, I., Harsanyi, A., Inotai, A., Jakupi, A., Henkuzens, S., Garuolienė, K., Gulbinovič, J., Bonanno, P. V., Rutkowski, J., Ingeberg, S., Melien, Ø., Mardare, I., Fürst, J., MacBride-Stewart, S., Holmes, C., Pontes, C., Zara, C., Pedrola, M. T., Hoffmann, M., Kourafalos, V., Pisana, A., Banzi, R., Campbell, S., Wettermark, B. (2023). Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International. doi: 10.1155/2021/9996193 Link

Inotai, A., Ágh, T., Maris, R., Erdősi, D., Kovács, S., Kaló, Z., Senkus, E. (2021). Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treatment Reviews. doi: 10.1016/j.ctrv.2021.102264 Link

Inotai, A., Jakab, I., Brixner, D., Campbell, J., Hawkins, N., Kristensen, L., Charokopou, M., Mountian, I., Szegvari, B., Kaló, Z. (2021). Proposal for Capturing Patient Experience through Extended Value Frameworks of Health Technologies. Journal of Managed Care & Specialty Pharmacy. doi: 10.18553/jmcp.2021.27.7.936 Link

Jakab, I., Whittington, M.D., Franklin, E., Raiola S., Campbell J. D., Kaló, Z., McQueen R. B. (2021). Patient and Payer Preferences for Additional Value Criteria. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.690021 Link

Kaló, Z., Németh, B., Zemplényi, A. (2021). Can cost–effectiveness principles be ignored in urgent times?. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2021-0211 Link

Kaló, Z., Petykó, Zs.I., Fricke, F-U., Maniadakis, N., Tesař, T., Podrazilová, K., Espin, J., Inotai, A. (2021). Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-021-00296-2 Link

Kardas, P., van Boven, J. F. M., Pinnock, H., Menditto, E., Wettermark, B., Tsiligianni, I., Ágh, T., ENABLE collaborators (2021). Disparities in European Healthcare System Approaches to Maintaining Continuity of Medication for Non-Communicable Diseases During the COVID-19 Outbreak. The Lancet Regional Health - Europe. doi: 10.1016/j.lanepe.2021.100099 Link

Kiss, Z., Bogos, K., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Knollmajer, K., Várnai, M., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Moldvay, J., Gálffy, G.,Vokó, Z. (2021). Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary. Pathology and Oncology Research doi: 10.3389/pore.2021.1610041 Link

Liszkay, G., Kiss, Z., Gyulai, R., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Benedek, A., Polányi, Z., Nagy-Erdei, Zs., Daniell, A., Knollmajer, K., Várnai, M., Vokó, Z., Nagy, B., Rokszin, Gy., Fábián, I., Barcza, Zs., Polgár, Cs. (2021). Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study. Frontiers in Oncology. doi: 10.3389/fonc.2020.612459 Link

Looman, W., Struckmann, V., Köppen, J., Baltaxe, E., Czypionka, T., Huic, M., Pitter, J., Ruths, S., Stokes, J., Bal, R., Rutten-van-Mölken, M. (2021). Drivers of Successful Implementation of Integrated Care for Multi-Morbidity: Mechanisms Identified in 17 Case Studies from 8 European Countries. Social Science & Medicine. doi: 10.1016/j.socsimed.2021.113728 Link

Méroc, E., Fröberg, J., Almási, T., Winje, B. A., Orrico-Sánchez, A., Steens, A., McDonald, S. A., Bollaerts, K., Knol, M. A. (2021). European Data Sources for Computing Burden of (Potential) Vaccine-Preventable Diseases in Aging Adults. BMC Infectious Diseases. doi: 10.1186/s12879-021-06017-7 Link

Nagy, B., Szilberhorn, L., Kerpel-Fronius, A., Moizs, M., Bajzik, G., Vokó, Z. (2021). The Budget Impact of Lung Cancer Screening With Low-Dose Computed Tomography. Orvosi Hetilap. doi: 10.1556/650.2021.32095 Link

Országh, E., Jóźwiak, Á., Süth, M., Micsinai, A., Urbányi, B., Vokó, Z., Kaló, Z., Pitter, J. Gy. (2021). Az egészségügyi technológiaértékelés és kockázat-haszon elemzés alkalmazási lehetőségei az élelmiszerlánc-biztonság területén. Magyar Állatorvosok Lapja. Link

Ozieranski, P., Pitter, J.G., Rickard. E., Mulinari, S., Csanadi, M. (2021). A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness. doi: 10.1111/1467-9566.13409 Link

Petykó, Zs.I., Kaló, Z., Espin, J., Podrazilová, K., Tesař, T., Maniadakis, N., Fricke, F-U., Inotai, A. (2021). Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-021-00311-6 Link

Pogány, G., Csanádi, M., Bódy, É., Bojtor, Zs., Kereki, J., Fadgyas-Freyler, P., Szabó, L., Kaló, Z. (2021). Bizonyítékokon alapuló egészségpolitikai döntéshozatal az integrált ellátásban - A Ritka Betegségek Nemzeti Erőforrás Központjának tervezési folyamata. Orvosi Hetilap. doi: 10.1556/650.2021.32244 Link

Pongiglione, B., Torbica, A., Blommestein, H., De Groot, S., Ciani, O., Walker, S., Dams, F., Blankart, R., Mollenkamp, M., Kovács, S., Tarricone, R., Drummond, M. (2021). Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal. International Journal of Technology Assessment in Health Care. doi:10.1017/S0266462321000301 Link

Sarri, G., Freitag, A., Szegvari, B., Mountain, I., Brixner, D., Bertelsen, N., Kaló, Z., Upadhyaya, S. (2021). The Role of Patient Experience In the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value Is Assessed? Health Policy. doi: 10.1016/j.healthpol.2021.03.006 Link

Thomsen, S. T., Assunção, R., Alfonso, C., Boué, G., Cardoso, C., Cubadda, F., Garre, A., Kruisselbrink, J. W., Mantovani, A., Pitter, J. G., Poulsen, M., Verhagen, H., Ververis, E., van der Voet, H., Watzl, B., Pires, S. M. (2021). Human Health Risk-Benefit Assessment of Fish and Other Seafood: A Scoping Review. Critical Reviews in Food Science and Nutrition. doi: 10.1080/10408398.2021.1915240 Link

van Boven, J. F. M., Tsiligianni, I., Potočnjak. I., Mihajlović, J., Dima, A. L., Nabergoj, M. U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., Wettermark, B. (2022). European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.748702 Link

Vellekoop, H. Huygens, S., Versteegh, M., Szilberhorn, L., Zelei, T., Nagy, B., Koleva-Kolarova, R., Tschiachristas, A., Wordsworth, S., Rutten-van Mölken, M. (2021). Guidance For The Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics. doi: 10.1007/s40273-021-01010-z Link

Vokó, Z., Kiss, Z., Surján, Gy., Surján, O., Barcza, Zs., Pályi, B., Formanek-Balku, E., Molnár, G. A., Herczeg, R.,  Gyenesei, A.,  Miseta, A., Kollár, L., Wittmann, I., Müller, C., Kásler, M. (2021). Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary - The HUN-VE study. Clinical Microbiology and Infection. doi: 10.1016/j.cmi.2021.11.011 Link

Zelei, T., Mendola, N. D., Elezbawy, B., Németh, B., Campbell, J. D. (2021). Criteria and Scoring Functions in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review. PharmacoEconomics - Open. doi: 10.1007/s41669-021-00271-w Link

Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., Pitter, J. Gy. (2021). Early Palliative Care Associated with Lower Costs for Adults with Advanced Cancer: Evidence From Hungary. European Journal of Cancer Care. doi: 10.1111/ecc.13473 Link

 

2020

Almási, T., Abul-Mad, E., George, M., Arnaiz, F., Elezbawy, B., Nagy, B., Kaló Z. (2020). Supporting Role of Non-Governmental Health Insurance Schemes in The Implementation of Universal Health Coverage in Developing Countries. Journal of Health Policy & Outcomes Research. doi:10.7365/JHPOR.2020.1.4 Link

Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., & Moldvay, J. (2020). Lung Cancer in Hungary. Journal of Thoracic Oncology, 15(5), 692-699. doi:10.1016/j.jtho.2019.11.001 Link

Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Rokszin, G., Abonyi-Tóth, Z., Moldvay, J. (2020). [Novel approaches to the epidemiology of lung cancer in Hungary]. Magyar Onkológia, 64(3), 175-181. Link

Csanádi, M., Ágh, T., Farkas-Ráduly, S., Gros, B., Tapprich, C., Trudeau, J. J., Lipton, J. H., & Mattsson, J. (2020). Patient-reported Symptom Burden of Chronic Graft Versus Host Disease: A Systematic Literature Review. Expert Review of Hematology. doi: 10.1080/17474086.2020.1818065 Link

Csanádi, M., Gini, A., Koning, H., Széles, G., Pitter, J.G., Oroszi, B., Pataki, P., Fadgyas-Freyler, P., Korponai, G., Vokó, Z., Lansdorp-Vogelaar, I. (2020). Modeling Costs and Benefits of the Organized Colorectal Cancer Screening Programme and Its Potential Future Improvements in Hungary. Journal of Medical Screening. doi:10.1177/0969141320968598 Link

Czypionka, T., Kraus, M., Reiss, M., Baltaxe, E., Roca, J., Ruths, S., Stokes, J., Struckmann, V., Haček, R. T., Zemplényi, A., Hoedemakers, M., & Rutten-van Mölken, M. (2020). The Patient at the Centre: Evidence From 17 European Integrated Care Programmes for Persons with Complex Needs. BMC Health Services Research, 20(1), 1102. doi:10.1186/s12913-020-05917-9 Link

Fasseeh, A.N., Karam, R., Jameleddine, M., George, M., Kristensen, F.B., Al-Rabayah, A., Alsaggabi, A., El Rabbat, M., Alowayesh, M., Chamova, J., Ismail, A. (2020). Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Frontiers in Pharmacology, 11, 15. doi: 10.3389/fphar.2020.00015 Link

Grigore, B., Ciani, O., Dams, F., Federici, C., de Groot, S., Möllenkamp, M., Rabbe, S., Shatrov, K., Zemplenyi, A., & Taylor, R. S. (2020). Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. PharmacoEconomics. doi:10.1007/s40273-020-00935-1 Link

Haluzík, M., Flekač, M., Lengyel, C., Taybani, Z., Guja, C., Mihai, B.-M., Cerghizan, A., Martinka, E., Kovacs, G., & Kempler, P. (2020). Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective. Diabetes Therapy, 11(4), 1029-1043. doi:10.1007/s13300-020-00777-2 Link

Inotai, A., Tomek, D., Niewada, M., Lorenzovici, L., Kolek, M., Weber, J., Kurrat, A., Kiss, E., Kalo, Z. (2020). Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries. Frontiers in Pharmacology. 11: 845. doi: 10.3389/fphar. Link

Jakab, I., Németh, B., Elezbawy, B., Karadayı, M.A., Tozan, H., Aydın, S., Shen, J., Kaló, Z. (2020). Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper-Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses. Frontiers in Pharmacology, 11, 1203. doi: 10.3389/fphar.2020.01203 Link

Kaló, Z., Zemplényi, A., Rutten-Van Molken, M., Looman, W., Huić, M., & Tandara, R. (2020). Development of Transferability Guidance for Integrated Care Models with Special Focus on Central and Eastern European countries. Croatian Medical Journal, 61(3), 252. doi: 10.3325/cmj.2020.61.252 Link

Kovács, G., Devercelli, G., Zelei, T., Hirji, I., Vokó, Z., Keown, P. A. (2020). Association Between Transplant Glomerulopathy and Graft Outcomes Following Kidney Transplantation: A Meta-Analysis. PLOS ONE, 15(4), e0231646. doi:10.1371/journal.pone.0231646 Link

Merkely, B., Szabó, A. J., Kosztin, A., Berényi, E., Sebestyén, A., Lengyel, C., Merkely, G., Karády, J., Várkonyi, I., Papp, C., Miseta, A., Betlehem, J., Burián, K., Csóka, I., Vásárhelyi, B., Ludwig, E., Prinz, G., Sinkó, J., Hankó, B., Varga, P., Fülöp, G., Mag, K., & Vokó, Z. (2020). Novel Coronavirus Epidemic in the Hungarian Population, A Cross-Sectional Nationwide Survey to Support the Exit policy in Hungary. GeroScience, 1-12. doi:10.1007/s11357-020-00226-9 Link

Németh, B., Goettsch, W., Kristensen, F. B., Pinyazhko, O., Huić, M., Tesař, T., Atanasijevic, D., Lipska, I., & Kaló, Z. (2020). The Transferability of Health Technology Assessment - the European Perspective with Focus on Central and Eastern European Countries. Expert Review of Pharmacoeconomic Outcomes Research. doi:10.1080/14737167.2020.1779061 Link

Németh, B., Kaló, Z. (2020). European Cooperation in Health Technology Assessment Implementation: The Perspective of Central and Eastern European Countries. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2020-0062 Link

Országh, E., Pitter, J. G., Kaló, Z., Vokó, Z., Józwiak, Á. (2020). Retrospective Cost-Utility Analysis of The Non-Typhoidal Salmonella Control Programme in Hungary. Food Control. doi: 10.1016/j.foodcont.2020.107529. Link

Ozieranski, P., Csanádi, M., Rickard, E., Mulinari, E. (2020). Under-Reported Relationship: A Comparative Study of Pharmaceutical Industry and Patient Organisation Payment Disclosures in the UK (2012–2016). BMJ Open. 2020 Sep 19;10(9):e037351. doi: 10.1136/bmjopen-2020-037351. Link

Petykó, Z. I., Inotai, A., Holtorf, A.-P., Brixner, D., Kaló, Z. (2020). Barriers and facilitators of exploiting the potential of value-added medicines. Expert Review of Pharmacoeconomics & Outcomes Research doi: 10.1080/14737167.2020.1758558 Link

Rais, C., Kaló, Z., Csanádi, M., Negulescu, V. (2020). Current and future perspectives for the implementation of health technology assessment in Romania. Health Policy and Technology, 9(1), 45-52. doi: 10.1016/j.hlpt.2019.11.007 Link

Rutten-van Mölken, M., Karimi, M., Leijten, F., Hoedemakers, M., Looman, W., Islam, K., Askildsen, J. E., Kraus, M., Ercevic, D., Struckmann, V., Gyorgy Pitter, J., Cano, I., Stokes, J., Jonker, M. (2020). Comparing patients’ and other stakeholders’ preferences for outcomes of integrated care for multimorbidity: a discrete choice experiment in eight European countries. BMJ Open, 10(10), e037547. doi:10.1136/bmjopen-2020-037547 Link

Vokó, Z., Pitter, J. G. (2020). The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis. GeroScience, 1–8. Advance online publication. https://doi.org/10.1007/s11357-020-00205-0 Link

Vokó, Z., Bitter, I., Mersich, B., Réthelyi, J., Molnár, A., Pitter, J. G., Götze, Á., Horváth, M., Kóczián, K., Fonticoli, L., Lelli, F., Németh, B. (2020). Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine. Cost Effectiveness and Resource Allocation, 18(1), 28. doi:10.1186/s12962-020-00224-w Link

Zemplényi, A. T., Csikós, Á., Csanádi, M., Mölken, M. R.-v., Hernandez, C., Pitter, J. G., Czypionka, T., Kraus, M., & Kaló, Z. (2020). Implementation of palliative care consult Service in Hungary – integration barriers and facilitators. BMC Palliative Care, 19(1). doi:10.1186/s12904-020-00541-0 Link

Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., & Pitter, J. G. (2020). Care Integration Decreases Hospitalization Costs: Retrospective Cohort Study of Palliative Care Consult Service for Hospital Patients With Metastatic Cancer. doi:10.21203/rs.3.rs-41113/v1 Link

 

2019

Abdullah, A. H., Holtorf, A.-P., Al-Hussaini, M., Lemay, J., Alowayesh, M., Kaló, Z. (2019). Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait. Journal of Pharmaceutical Policy and Practice, 12, 9-9. doi: 10.1186/s40545-019-0171-4 Link

Agh, T., Csanadi, M., Voko, Z., Webb, T., Jeyakumaran, D., Trudeau, J., Sengupta, N., Schain, F., Mattsson, J. (2019). Humanistic burden of patients with chronic graft-versus-host disease-systematic literature review of health-related quality of life and functional status. Expert Review of Hematology, 12(5), 295-309. doi: 10.1080/17474086.2019.1602036​ Link

Almási, T., Guey, L. T., Lukacs, C., Csetneki, K., Vokó, Z., Zelei, T. (2019). Systematic literature review and meta-analysis on the epidemiology of propionic acidemia. Orphanet Journal of Rare Diseases, 14(1). doi: 10.1186/s13023-018-0987-z​ Link

Almási, T., Guey, L. T., Lukacs, C., Csetneki, K., Vokó, Z., Zelei, T. (2019). Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Orphanet Journal of Rare Diseases, 14(1). doi: 10.1186/s13023-019-1063-z​ Link

Baltaxe, E., Czypionka, T., Kraus, M., Reiss, M., Askildsen, J. E., Grenkovic, R., Lindén, T. S., Pitter, J. G., Rutten-van Molken, M., Solans, O., Stokes, J., Struckmann, V., Roca, J., Cano, I. (2019). Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs. Journal of Medical Internet Research, 21(9), e14956. doi: 10.2196/14956 Link

Bendes, R., Németh, B., Pitter, J.G., Kóczián, K., Götze, Á., Kaló, Z. (2019). Magyarországon becsült életminőséggel korrigált életévnyereség lehetősége a negatív tünetes szkizofréniában kariprazin alkalmazása esetén. LAM. 2019. 29(10). 467-475. Link

Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Moldvay, J. (2019). Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary. Frontiers in Oncology, 9. doi: 10.3389/fonc.2019.01051 Link

Csanadi, M., Agh, T., Tordai, A., Webb, T., Jeyakumaran, D., Sengupta, N., Schain, F., Mattsson, J. (2019). A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology, 12(5), 311-323. doi: 10.1080/17474086.2019.1605288​ Link

Csanádi, M., Inotai, A., Oleshchuk, O., Lebega, O., Alexandra, B., Piniazhko, O., Németh, B., Kaló, Z. (2019). Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives. International Journal of Technology Assessment in Health Care, 35(5), 393-400. doi: 10.1017/s0266462319000679​ Link

Csanádi, M., Löblová, O., Ozierański, P., Harsányi, A., Kaló, Z., McKee, M., King, L. (2018). When health technology assessment is confidential and experts have no power: the case of Hungary. Health Economics, Policy and Law, 14(2), 162-181. doi: 10.1017/s1744133118000051 Link

Csanádi, M., de Kok, I. M. C. M., Heijnsdijk, E. A. M., Anttila, A., Heinävaara, S., Pitter, J. G., Széles, G., Ivanuš, U., Priaulx, J., Veerus, P., Senore, C., Koning, H. J. d., Vokó, Z. (2019). Key indicators of organized cancer screening programs: Results from a Delphi study. Journal of Medical Screening, 26(3), 120-126. doi: 10.1177/0969141318820362 Link

Csanádi, M., Ozierański, P., Löblová, O., King, L., Kaló, Z., Botz, L. (2019). Shedding light on the HTA consultancy market: Insights from Poland. Health Policy, 123(12), 1237-1243. doi: 10.1016/j.healthpol.2019.08.008 Link

Freijer, K., Volger, S., Pitter, J. G., Molsen-David, E., Cooblall, C., Evers, S., Hiligsmann, M., Danel, A., Lenoir-Wijnkoop, I. (2019). Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group. Value in Health, 22(1), 1-12. doi: 10.1016/j.jval.2018.07.879 Link

Harsányi, A., Csanádi, M., Márky, K., Vincziczki, Á. Z., Kaló, Z., Inotai, A. (2019). Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary. Expert Review of Pharmacoeconomics & Outcomes Research, 1-7. doi: 10.1080/14737167.2019.1667232 Link

Holtorf, A.-P., Gialama, F., Wijaya, K. E., Kaló, Z. (2019). External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage. Value in Health Regional Issues, 19, 122-131. doi: 10.1016/j.vhri.2019.04.003 Link

Inotai, A., Kaló, Z. (2019). How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries?–the good, the bad, and the ugly ways. Expert Review of Pharmacoeconomics & Outcomes Research, 19(6), 627-632. doi: 10.1080/14737167.2019.1702524 Link

Kaló, Z., van den Akker, L. H. M., Vokó, Z., Csanádi, M., Pitter, J. G. (2019). Is there a fair allocation of healthcare research funds by the European Union? PLOS ONE, 14(4), e0207046. doi:10.1371/journal.pone.0207046 Link

Lukács, G., Kovács, Á., Csanádi, M., Moizs, M., Repa, I., Kaló, Z., Vokó, Z., Pitter, J. G. (2019). Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence. Cancer Management and Research, Volume 11, 9849-9861. doi:10.2147/cmar.s221427.Link

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology. Health Policy, 123(7), 630-634. doi: 10.1016/j.healthpol.2019.05.012 Link

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy, 123(8), 713-720. doi: 10.1016/j.healthpol.2019.05.021 Link

Nemeth. B. (2019). Possibility of Quality-adjusted Life Year Gain with Cariprazine in Patients with Negative Symptoms of Schizophrenia in Hungary (in Hungarian). Lege Artis Medicinæ - 2019;29(08-09):389–394. doi: 10.33616/lam.29.040 Link

Németh, B., Bendes, R., Nagy, B., Götze, Á., Kóczián, K., Horváth, M., Deák, I., Tóth, B., Kaló, Z. (2019). Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia. Health Policy and Technology, 8(1), 84-91. doi: 10.1016/j.hlpt.2019.01.004​ Link

Németh, B., Molnár, A., Bozóki, S., Wijaya, K., Inotai, A., Campbell, J. D., Kaló, Z. (2019). Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries. Journal of Comparative Effectiveness Research, 8(4), 195-204. doi: 10.2217/cer-2018-0102​ Link

Pednekar, P. P., Ágh, T., Malmenäs, M., Raval, A. D., Bennett, B. M., Borah, B. J., Hutchins, D. S., Manias, E., Williams, A. F., Hiligsmann, M., Turcu-Stiolica, A., Zeber, J. E., Abrahamyan, L., Bunz, T. J., Peterson, A. M. (2019). Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health, 22(2), 139-156. doi: 10.1016/j.jval.2018.08.006 Link

Pitter, J. G., Csanádi, M., Szigeti, A., Lukács, G., Kovács, Á., Moizs, M., Repa, I., Zemplényi, A., Czypionka, T., Kraus, M., Rutten-van Mölken, M. P. M. H., Kaló, Z. (2019). Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study. BMC Health Services Research, 19(1). doi: 10.1186/s12913-019-3957-9​ Link 

Tesar, T., Obsitnik, B., Kaló, Z., Kristensen, F. B. (2019). How changes in reimbursement practices influence the financial sustainability of medicine policy: lessons learned from Slovakia. Frontiers in Pharmacology, 10, 664. doi: 10.3389/fphar.2019.00664 Link

Szilberhorn, L., Kaló, Z., Ágh, T. (2019). Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature review. Antiviral Therapy, 24(4), 247-259. doi: 10.3851/imp3290 Link 

Szilberhorn, L., Kőrösi, L., Vajer, P., Nagy, B., Vokó, Z. (2019). Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary. Primary Care Diabetes, 13(5), 462-467. doi: 10.1016/j.pcd.2019.03.004 Link

 

2018

Ágh, T., Gáspár, K., Nagy, B., Lehmann, M., Kaló, Z. (2018). The value of a child born in the European Union. Acta Oeconomica, 68(2), 295-309. doi: 10.1556/032.2018.68.2.6​ Link

Begum, M., Lewison, G., Jassem, J., Mixich, V., Cufer, T., Nurgozhin, T., Shabalkin, P., Kutluk, T., Voko, Z., Radosavljevic, D., Vrdoljiak, E., Eniu, A., Walewski, J., Aggarwal, A., Lawler, M., Sullivan, R. (2018). Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning. European Journal of Cancer, 104, 127-136. doi: 10.1016/j.ejca.2018.08.024​ Link

Bochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., Duborija-Kovacevic, N., Fürst, J., Gaga, M., Gailīte, E., Gulbinovič, J., Gürpınar, E. U., Hankó, B., Hargaden, V., Hotvedt, T. A., Hoxha, I., Huys, I., Inotai, A., Jakupi, A., Jenzer, H., Joppi, R., Laius, O., Lenormand, M.-C., Makridaki, D., Malaj, A., Margus, K., Marković-Peković, V., Miljković, N., de Miranda, J. L., Primožič, S., Rajinac, D., Schwartz, D. G., Šebesta, R., Simoens, S., Slaby, J., Sović-Brkičić, L., Tesar, T., Tzimis, L., Warmińska, E., Godman, B. (2018). Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00942 Link

Brixner, D., Kaló, Z., Maniadakis, N., Kim, K., Wijaya, K. (2018). An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets. Value in Health Regional Issues, 16, 9-13. doi: 10.1016/j.vhri.2018.01.003 Link

Campbell, J. D., Kaló, Z. (2018). Fair global drug pricing. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 581-583. doi: 10.1080/14737167.2018.1524296​ Link

Csanádi, M., Kaló, Z., Prins, C. P. J., Grélinger, E., Menczelné Kiss, A., Fricke, F.-U., Fuksa, L., Tesar, T., Manova, M., Lorenzovici, L., Vokó, Z., Garrison, L. P. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology, 7(3), 243-250. doi: 10.1016/j.hlpt.2018.07.005​ Link

Fasseeh, A., Németh, B., Molnár, A., Fricke, F. U., Horváth, M., Kóczián, K., Götze, Á., Kaló, Z. (2018). A systematic review of the indirect costs of schizophrenia in Europe. European Journal of Public Health, 28(6), 1043-1049. doi: 10.1093/eurpub/cky231​ Link

Freijer, K., Volger, S., Pitter, J. G., Molsen-David, E., Cooblall, C., Evers, S., Hiligsmann, M., Danel, A., Lenoir-Wijnkoop, I. (2019). Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group. Value in Health, 22(1), 1-12. doi: 10.1016/j.jval.2018.07.879 Link

Gyulai, A., Nagy, A., Pataki, V., Tonté, D., Ádány, R., Vokó, Z. (2018). General practitioners can increase participation in cervical cancer screening – a model program in Hungary. BMC Family Practice, 19(1). doi: 10.1186/s12875-018-0755-0 Link

Inotai, A., Ágh, T., Karpenko, A. W., Zemplényi, A., Kaló, Z. (2018). Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 19(2), 105-113. doi: 10.1080/14737167.2019.1554437 Link

Inotai, A., Nguyen, H. T., Hidayat, B., Nurgozhin, T., Kiet, P. H. T., Campbell, J. D., Németh, B., Maniadakis, N., Brixner, D., Wijaya, K., Kaló, Z. (2018). Guidance toward the implementation of multicriteria decision analysis framework in developing countries. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 585-592. doi: 10.1080/14737167.2018.1508345 Link

Inotai, A., Csanadi, M., Petrova, G., Dimitrova, M., Bochenek, T., Tesar, T., York, K., Fuksa, L., Kostyuk, A., Lorenzovici, L., Omelyanovskiy, V., Egyed, K., Kalo, Z. (2018). Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International, 2018, 1-9. doi: 10.1155/2018/9597362​ Link

Inotai, A., Brixner, D., Maniadakis, N., Dwiprahasto, I., Kristin, E., Prabowo, A., Yasmina, A., Priohutomo, S., Németh, B., Wijaya, K., Kalo, Z. (2018). Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia. BMC health services research, 18(1), 1003-1003. doi: 10.1186/s12913-018-3805-3​ Link

Kamusheva, M., Manova, M., Savova, A. T., Petrova, G. I., Mitov, K., Harsányi, A., Kaló, Z., Márky, K., Kawalec, P., Angelovska, B., Lakić, D., Tesar, T., Draganic, P., Geitona, M., Hatzikou, M., Paveliu, M. S., Männik, A. (2018). Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries. Frontiers in Pharmacology, 9. doi: 10.3389/fphar.2018.00795​ Link

Kolasa, K., Zwolinski, K. M., Zah, V., Kaló, Z., Lewandowski, T. (2018). Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0803-9 Link

Kovács, G., Almási, T., Millier, A., Toumi, M., Horváth, M., Kóczián, K., Götze, À., Kaló, Z., Zemplényi, A. T. (2018). Direct healthcare cost of schizophrenia – European overview. European Psychiatry, 48(1), 79-92. doi: 10.1016/j.eurpsy.2017.10.008 Link

Kulchaitanaroaj, P., Kaló, Z., West, R., Cheung, K. L., Evers, S., Vokó, Z., Hiligsmann, M., de Vries, H., Owen, L., Trapero-Bertran, M., Leidl, R., Pokhrel, S. (2018). Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study. BMC Health Services Research, 18(1). doi: 10.1186/s12913-018-2923-2​ Link

Leijten, F. R. M., Hoedemakers, M., Struckmann, V., Kraus, M., Cheraghi-Sohi, S., Zemplényi, A., Ervik, R., Vallvé, C., Huiĉ, M., Czypionka, T., Boland, M., Rutten-van Mölken, M. P. M. H. (2018). Defining good health and care from the perspective of persons with multimorbidity: results from a qualitative study of focus groups in eight European countries. BMJ Open, 8(8), e021072. doi: 10.1136/bmjopen-2017-021072 Link

Nemeth, B. (2018). Health Economics in Hungary: Great potential, missed opportunity? [in Hungarian]. LEGE ARTIS MEDICINÆ- 28(06-07). Link

Németh, B., Józwiak-Hagymásy, J., Kovács, G., Kovács, A., Demjén, T., Huber, M. B., Cheung, K.-L., Coyle, K., Lester-George, A., Pokhrel, S., Vokó, Z. (2018). Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD. Addiction, 113, 76-86. doi: 10.1111/add.14089 Link

Németh, B., Fasseeh, A., Molnár, A., Bitter, I., Horváth, M., Kóczián, K., Götze, Á., Nagy, B. (2018). A systematic review of health economic models and utility estimation methods in schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research, 18(3), 267-275. doi: 10.1080/14737167.2018.1430571 Link

Németh, B., Kulchaitanaroaj, P., Lester-George, A., Huic, M., Coyle, K., Coyle, D., Pokhrel, S., Kaló, Z. (2018). A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study. Addiction, 113, 42-51. doi: 10.1111/add.14092 Link

Nestler-Parr, S., Korchagina, D., Toumi, M., Pashos, C. L., Blanchette, C., Molsen, E., Morel, T., Simoens, S., Kaló, Z., Gatermann, R., Redekop, W. (2018). Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group. Value in Health, 21(5), 493-500. doi: 10.1016/j.jval.2018.03.004​ Link

Ozierański, P., Löblová, O., Nicholls, N., Csanádi, M., Kaló, Z., McKee, M., King, L. (2018). Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015. Health Economics, Policy and Law, 14(2), 182-204. doi: 10.1017/s1744133117000342​ Link 

Pitter, J. G., Vokó, Z., Józwiak, Á., Berkics, A. (2018). Campylobacter control measures in indoor broiler chicken: critical re-assessment of cost-utility and putative barriers to implementation. Epidemiology and Infection, 146(11), 1433-1444. doi: 10.1017/s0950268818001528​ Link

Pitter, J. G., Lukács, G., Csanádi, M., Vokó, Z. (2018). Clinical impact of treatment delay in pancreatic cancer patients revisited. International Journal of Cancer, 142(12), 2621-2622. doi: 10.1002/ijc.31263 Link

Priaulx, J., Csanádi, M., de Koning, H. J., McKee, M. (2018). A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs. The International Journal of Health Planning and Management, 34(1), e34-e45. doi: 10.1002/hpm.2697​ Link

Priaulx, J., de Koning, H. J., de Kok, I. M. C. M., Széles, G., McKee, M. (2018). Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty-one European countries using the Barriers to Effective Screening Tool (BEST). Health Policy, 122(11), 1190-1197. doi: 10.1016/j.healthpol.2018.08.004 Link 

Rutten- van Molken, M., Leijten, F., Hoedemakers, M., Tsicahristas, A., Verbeek, N., Bal, R., De Bont, A., Islam, K., Askildsen, J.-E., Czypionka, T., Huic, M., Pitter, J., Vogt, V., Stokes, J., Baltaxe, E. (2018). Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analyses MCDA. International Journal of Integrated Care, 18(s2), 315. doi: 10.5334/ijic.s2315​ Link

Szegedi, M., Zelei, T., Arickx, F., Bucsics, A., Cohn-Zanchetta, E., Fürst, J., Kamusheva, M., Kawalec, P., Petrova, G., Slaby, J., Stawowczyk, E., Vocelka, M., Zechmeister-Koss, I., Kaló, Z., Molnár, M. J. (2018). The European challenges of funding orphan medicinal products. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0927-y​ Link

Trapero-Bertran, M., Muñoz, C., Coyle, K., Coyle, D., Lester-George, A., Leidl, R., Németh, B., Cheung, K.-L., Pokhrel, S., Lopez-Nicolás, Á. (2018). Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD. Addiction, 113, 65-75. doi: 10.1111/add.14090 Link

Turnbull, E., Priaulx, J., van Ravesteyn, N. T., Heinävaara, S., Siljander, I., Senore, C., Segnan, N., Vokó, Z., Hagymásy, J., Jarm, K., Veerus, P., de Koning, H. J., McKee, M. (2018). A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries. Health Policy, 122(11), 1198-1205. doi: 10.1016/j.healthpol.2018.08.003 Link

Turnbull, E., Priaulx, J., de Kok, I. M. C. M., Lansdorp-Vogelaar, I., Anttila, A., Sarkeala, T., Senore, C., Segnan, N., Csanádi, M., Pitter, J., Novak Mlakar, D., Ivanus, U., Veerus, P., de Koning, H. J., McKee, M. (2018). Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries. Health Policy, 122(11), 1206-1211. doi: 10.1016/j.healthpol.2018.08.005 Link 

Zelei, T., Csetneki, K., Vokó, Z., Siffel, C. (2018). Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0796-4 Link

 

2017

Brixner, D., Maniadakis, N., Kaló, Z., Hu, S., Shen, J., Wijaya, K. (2017). Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets. Value in Health Regional Issues, 13, 1-6. doi: 10.1016/j.vhri.2017.02.001 Link

Coyle, K., Coyle, D., Lester-George, A., West, R., Nemeth, B., Hiligsmann, M., Trapero-Bertran, M., Leidl, R., Pokhrel, S. (2017). Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation. Addiction, 113, 7-18. doi: 10.1111/add.14001​ Link

Elek, P., Harsányi, A., Zelei, T., Csetneki, K., Kaló, Z. (2017). Policy objective of generic medicines from the investment perspective: The case of clopidogrel. Health Policy, 121(5), 558-565. doi: 10.1016/j.healthpol.2017.02.015 Link

Elek, P., Takács, E., Merész, G., Kaló, Z. (2016). Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy and Planning, czw133. doi: 10.1093/heapol/czw133​ Link

Huber, M. B., Präger, M., Coyle, K., Coyle, D., Lester-George, A., Trapero-Bertran, M., Nemeth, B., Cheung, K. L., Stark, R., Vogl, M., Pokhrel, S., Leidl, R. (2017). Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD. Addiction, 113, 52-64. doi: 10.1111/add.14062 Link

Inotai, A., Csanádi, M., Harsányi, A., Németh, B. (2017). Drug Policy in Hungary. Value in Health Regional Issues, 13, 16-22. doi: 10.1016/j.vhri.2017.06.003​ Link

Inotai, A., Csanadi, M., Vitezic, D., Francetic, I., Tesar, T., Bochenek, T., Lorenzovici, L., Dylst, P., Kalo, Z. (2017). Policy Practices to Maximise Social Benefit from Biosimilars. Journal of Bioequivalence & Bioavailability, 09(04). doi: 10.4172/jbb.1000346 Link

Inotai, A., Prins, C. P. J., Csanádi, M., Vitezic, D., Codreanu, C., Kaló, Z. (2017). Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars. Expert Opinion on Biological Therapy, 17(8), 915-926. doi: 10.1080/14712598.2017.1341486 Link

Kaló, Z., Abonyi-Tóth, Z., Rokszin, G., Ágh, T., Inotai, A. (2017). Impact of multiple switching on health care costs and outcomes in generic drug policies: The Hungarian case of losartan. Acta Poloniae Pharmaceutica-Drug Research, 74(4), 1295-1300.  Link

Kaló, Z., Vokó, Z., Östör, A., Clifton-Brown, E., Vasilescu, R., Battersby, A., Gibson, E. (2017). Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. Journal of Market Access & Health Policy, 5(1), 1345580. doi: 10.1080/20016689.2017.1345580 Link

Kawalec, P., Tesar, T., Vostalova, L., Draganic, P., Manova, M., Savova, A., Petrova, G., Rugaja, Z., Männik, A., Sowada, C., Stawowczyk, E., Harsanyi, A., Inotai, A., Turcu-Stiolica, A., Gulbinovič, J., Pilc, A. (2017). Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00892 Link

Kovács, G., Somogyvári, Z., Maka, E., Nagyjánosi, L. (2017). Bedside ROP screening and telemedicine interpretation integrated to a neonatal transport system: Economic aspects and return on investment analysis. Early Human Development, 106-107, 1-5. doi: 10.1016/j.earlhumdev.2017.01.007​ Link

Molnár, A., Nagy, B., Kerpel-Fronius, A., Bajzik, G., Horváth, I., Moizs, M., Vokó, Z. (2017). Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary. Value in Health, 20(9), A750. doi: 10.1016/j.jval.2017.08.2096 Link

Nagy, B., Setyawan, J., Coghill, D., Soroncz-Szabo, T., Kalo, Z., Doshi, J.A. (2017). A conceptual framework for a long-term economic model of the treatment of attention-deficit/hyperactivity disorder. Expert Review of Pharmacoeconomics & Outcomes Research 17. 3. 283-292. doi: 10.1080/14737167.2017.1271325  Link

Narbutas, Š., York, K., Stein, B. D., Magsanoc-Alikpala, K., Majima, Y., Kalo, Z., Almasi, T., Inotai, A. (2017). Overview on Patient Centricity in Cancer Care. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00698 Link

Németh, B., Csanádi, M., Kaló, Z. (2017). Overview on the current implementation of health technology assessment in the healthcare system in Hungary. International Journal of Technology Assessment in Health Care, 33(3), 333-338. doi: 10.1017/s0266462317000071 Link

Németh, B., Molnár, A., Akehurst, R., Horváth, M., Kóczián, K., Németh, G., Götze, Á., Vokó, Z. (2017). Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone. Journal of Comparative Effectiveness Research, 6(8), 639-648. doi: 10.2217/cer-2017-0024​ Link

Pitter, J. G., Horváth, B., Abonyi-Tóth, Z., Rokszin, G., Fadgyas-Freyler, P., Kovács, G., Ács, N., Kaló, Z., Vokó, Z. (2017). Drug-associated miscarriage, teratogenicity and low birthweight risks: Methods for population-based case-control studies in Hungary. Reproductive Toxicology, 72, 26. doi: 10.1016/j.reprotox.2017.06.064 Link

Rosselli, D., Quirland-Lazo, C., Csanádi, M., Ruiz de Castilla, E. M., González, N. C., Valdés, J., Abicalaffe, C., Garzón, W., Leon, G., Kaló, Z. (2017). HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status. Value in Health Regional Issues, 14, 20-27. doi: 10.1016/j.vhri.2017.02.004​ Link 

Tesar, T., Szilberhorn, L., Nemeth, B., Nagy, B., Wawruch, M., Kalo, Z. (2017). Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00946​ Link

Voko, Z., Barra, M., Molnar, A., Kerpel-Fronius, A., Bajzik, G., Horvath, I., Moizs, M., Nagy, B. (2017). Model concept of the health economic evaluation of low-dose CT lung cancer screening in Hungary. [in Hungarian] ORVOSI HETILAP 158.25. pp. 963–975. doi: 10.1556/650.2017.30731 Link

Vokó, Z., Gáspár, K., Inotai, A., Horváth, C., Bors, K., Speer, G., Kaló, Z. (2017). Osteoporotic fractures may impair life as much as the complications of diabetes. Journal of Evaluation in Clinical Practice, 23(6), 1375-1380. doi: 10.1111/jep.12800 Link

 

2016

Ágh, T., Kovács, G., Supina, D., Pawaskar, M., Herman, B. K., Vokó, Z., Sheehan, D. V. (2016). A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 21(3), 353-364. doi: 10.1007/s40519-016-0264-x Link

Ágh, T., Pawaskar, M., Nagy, B., Lachaine, J., Vokó, Z. (2016). The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA. Clinical Drug Investigation, 36(4), 305-312. doi: 10.1007/s40261-016-0381-3 Link

Bodnár, R., Meszaros, A., Olah, M., Agh, T. (2016). Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes. Patient Preference and Adherence, 183. doi: 10.2147/ppa.s53653 Link

Cheung, K. L., Evers, S. M. A. A., Hiligsmann, M., Vokó, Z., Pokhrel, S., Jones, T., Muñoz, C., Wolfenstetter, S. B., Józwiak-Hagymásy, J., de Vries, H. (2016). Understanding the stakeholders’ intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool. Health Policy, 120(1), 46-54. doi: 10.1016/j.healthpol.2015.11.004 Link

Elek, P., Takács, E., Merész, G., Kaló, Z. (2016). Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy and Planning, czw133. doi: 10.1093/heapol/czw133 Link

Glonti, K., Pitter, J., Csanadi, M., Vokó, Z., McKee, M. (2016). Health system factors associated with uptake of cancer screening: an overview of systematic reviews. European Journal of Public Health, 26(suppl_1). doi: 10.1093/eurpub/ckw169.068 Link

Inotai, A., Csanadi, M., Agh, T. (2016). Real-world data analysis to improve drug policy decision-making in Central Eastern European countries. [in Hungarian] IME INTERDISZCIPLINARIS MAGYAR EGESZSEGUGY 15: 47-52. Link

Kaló, Z., Gheorghe, A., Huic, M., Csanádi, M., Kristensen, F. B. (2016). HTA Implementation Roadmap in Central and Eastern European Countries. Health Economics, 25, 179-192. doi: 10.1002/hec.3298 Link

Kaló, Z., Vokó, Z., Akhras, K. S., Kanavos, P. (2016). Response to: Comment on the implications of external price referencing of pharmaceuticals in Middle East countries. Expert Review of Pharmacoeconomics & Outcomes Research, 16(1), 15-16. doi: 10.1586/14737167.2016.1136792 Link

Kaló, Z., Vokó, Z., Clifton-Brown, E., Vasilescu, R. S., David, T., Gibson, E., Begum, N., Rao, N. (2016). Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe. Value in Health, 19(7), A547-A548. doi: 10.1016/j.jval.2016.09.1163 Link

Kolasa, K., Zwolinski, K. M., Kalo, Z., Hermanowski, T. (2016). Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs. Orphanet Journal of Rare Diseases, 11(1). doi: 10.1186/s13023-016-0388-0 Link

Kolasa, K., Kalo, Z., Zah, V. (2016). The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations. Expert Review of Pharmacoeconomics & Outcomes Research, 16(4), 483-488. doi: 10.1080/14737167.2016.1215917 Link

Kovács, G., Zelei, T., Vokó, Z. (2016). Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis. Climacteric, 19(5), 488-495. doi: 10.1080/13697137.2016.1221919 Link

Marsh, K., Ijzerman, M., Thokala, P., Baltussen, R., Boysen, M., Kaló, Z., Lönngren, T., Mussen, F., Peacock, S., Watkins, J., Devlin, N. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health, 19(2), 125-137. doi: 10.1016/j.jval.2015.12.016​ Link

Nagy, B., Zsólyom, A., Nagyjánosi, L., Merész, G., Steiner, T., Papp, E., Dessewffy, Z., Jermendy, G., Winkler, G., Kaló, Z., Vokó, Z. (2016). Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes. Diabetes/Metabolism Research and Reviews, 32(7), 710-729. doi: 10.1002/dmrr.2791 Link

Nagy, B., Setyawan, J., Coghill, D., Soroncz-Szabó, T., Kaló, Z., Doshi, J. A. (2016). A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder. Expert Review of Pharmacoeconomics & Outcomes Research, 17(3), 283-292. doi: 10.1080/14737167.2017.1271325 Link

Vokó, Z., Cheung, K. L., Józwiak-Hagymásy, J., Wolfenstetter, S., Jones, T., Muñoz, C., Evers, S. M. A. A., Hiligsmann, M., de Vries, H., Pokhrel, S. (2016). Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Research Policy and Systems, 14(1). doi: 10.1186/s12961-016-0110-7 Link

Thokala, P., Devlin, N., Marsh, K., Baltussen, R., Boysen, M., Kalo, Z., Longrenn, T., Mussen, F., Peacock, S., Watkins, J., Ijzerman, M. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making-An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016. 19(1). 1-13. doi: 10.1016/j.jval.2015.12.003 Link

Voko, Z., Turi, G., Zsolyom, A. (2016). Cost-effectiveness of oral cancer screening in Hungary. [in Hungarian] ORVOSI HETILAP 157(29), 1161–1170. doi: 10.1556/650.2016.30447 Link

Voko, Z., Zsolyom, A., Jermendy, Gy. (2016). Diabetes attributable mortality in Hungary in 2000-2009.[in Hungarian] LEGE ARTIS MEDICINAE 26:265-270.  Link

Zelei, T., Molnár, M. J., Szegedi, M., Kaló, Z. (2016). Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries. Orphanet Journal of Rare Diseases, 11(1). doi: 10.1186/s13023-016-0455-6 Link

Zemplenyi, A.T., Mangel, L., Kalo, Z., Endrei, D., Boncz, I. (2016). A microcosting study of radiation therapy of localized prostate cancer. (in Hungarian) ORVOSI HETILAP 157. 12. 461-8. doi: 10.1556/650.2016.30392 Link

Zemplenyi, A.T., Mangel, L., Kalo, Z., Endrei, D., Lohner, S., Boncz, I. (2016). Meta-analysis of the side-effect profiles of modern radiation therapies for patients with prostate cancer (Article in Hungarian). ORVOSI HETILAP 157(20):776-88. doi: 10.1556/650.2016.30422 Link

Zemplényi, A.T., Kaló, Z., Kovács, G., Farkas, R., Beöthe, T., Bányai, D., Sebestyén, Z., Endrei, D., Boncz, I., Mangel, L. (2016). Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer. European Journal of Cancer Care, 27(1), e12430. doi: 10.1111/ecc.12430 Link

 

2015 

Ágh, T., Bodnár, R., Oláh, M., Mészáros, Á. (2015). Adherence to Inhaled Antibiotics for The Treatment of Chronic Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis: A Systematic Literature Review. Value in Health, 18(7), A760. doi: 10.1016/j.jval.2015.09.2480 Link

Ágh, T., Kovács, G., Pawaskar, M., Supina, D., Inotai, A., Vokó, Z. (2015). Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 20(1), 1-12. doi: 10.1007/s40519-014-0173-9 Link

Ágh, T., Dömötör, P., Bártfai, Z., Inotai, A., Fujsz, E., Mészáros, Á. (2015). Relationship between medication adherence and health-related quality of life in subjects with COPD: a systematic review. Respiratory Care, 60(2), 297-303. doi: 10.4187/respcare.03123 Link

Bartfai, Z., Agh, T., Domotor, P., Bartfai, L., Meszaros, A. (2015). Therapeutic opportunities derived from clinical differences among inhaled corticosteroids. [in Hungarian] MEDICINA THORACALIS 5:339-344.

Drummond, M., Augustovski, F., Kaló, Z., Yang, B.-M., Pichon-Riviere, A., Bae, E.-Y., Kamal-Bahl, S. (2015). CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES. International Journal of Technology Assessment in Health Care, 31(6), 442-448. doi: 10.1017/s0266462315000604​ Link

Gyulai, A., Nagy, A., Pataki, V., Tonté, D., Ádány, R., Vokó, Z. (2015). Survey of Participation in Organised Cervical Cancer-Screening Programme in Hungary. Cent Eur J Public Health, 23(4), 360-364. doi: 10.21101/cejph.a4068 Link

Inotai, A., Abonyi-Tóth, Z., Rokszin, G., Vokó, Z. (2015). Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary. Value in Health Regional Issues, 7, 1-8. doi: 10.1016/j.vhri.2015.03.020 Link

Inotai, A., Merész, G., Csetneki, K., Kaló, Z. (2015). A gyógyszerkiadások nemzetközi összehasonlításának módszertani kérdései és ezek hatásai a magyarországi kormányzati intézkedésekre. IME. 2015. 14. 8. 55-60. Link

Jozwiak-Hagymasy, J., Voko, Z. (2015). Use of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus panel [in Hungarian] IME 14:1 48:53. Link

Kaló, Z., Alabbadi, I., Al Ahdab, O. G., Alowayesh, M., Elmahdawy, M., Al-Saggabi, A. H., Tanzi, V. L., Al-Badriyeh, D., Alsultan, H. S., Ali, F. M. H., Elsisi, G. H., Akhras, K. S., Vokó, Z., Kanavos, P. (2015). Implications of external price referencing of pharmaceuticals in Middle East countries. Expert Review of Pharmacoeconomics & Outcomes Research, 15(6), 993-998. doi: 10.1586/14737167.2015.1048227 Link

Kaló, Z., Holtorf, A.-P., Alfonso-Cristancho, R., Shen, J., Ágh, T., Inotai, A., Brixner, D. (2015). Need for Multicriteria Evaluation of Generic Drug Policies. Value in Health, 18(2), 346-351. doi: 10.1016/j.jval.2014.12.012 Link

Kind, P., Vokó, Z. (2015). A National Eq-5d Value Set for Hungary - a Model Methodology? Value in Health, 18(7), A738. doi: 10.1016/j.jval.2015.09.2833 Link

Mandrik, O., Knies, S., Kalo, Z., Severens, J. L. (2015). REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE. International Journal of Technology Assessment in Health Care, 31(6), 434-441. doi: 10.1017/s0266462315000677 Link

Nagy, B. (2015). Improving the allocation of health care resources in Poland. WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE. Link

Oyebode, O., Garrett, Z., George, E., Cangini, A., Muscolo, L. A. A., Warren, S., Nemeth, B., Földesi, C., Heislerová, M., Gajdošová, E. (2015). EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE. International Journal of Technology Assessment in Health Care, 31(1-2), 59-67. doi: 10.1017/s0266462315000227 Link

Pawaskar, M., Vokó, Z., Ágh, T., Sheehan, D. V., McElroy, S. L., Radewonuk, J., Merész, G., Herman, B. K., Gasior, M. (2015). Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder. Value in Health, 18(7), A407. doi: 10.1016/j.jval.2015.09.959 Link

Pawaskar, M., Ágh, T., Radewonuk, J., Vokó, Z., McElroy, S. L., Herman, B. K., Gasior, M. (2015). Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder. Value in Health, 18(7), A407. doi: 10.1016/j.jval.2015.09.958 Link

Pitter, J., Jozwiak, A., Martos, E., Kaló, Z., Vokó, Z. (2015).  Next steps to evidence-based food safety risk analysis: opportunities for health technology assessment methodology implementation. Studies in Agricultural Economics, 117. 155-161. doi: 10.7896/j.1524 Link

Pitter, J. G., Vokó, Z., Halmos, Á., Józwiak, Á. (2015). Cost-Utility Analysis of Potential Campylobacter Control Measures in the Food Chain of Indoor Broiler Chicken in the Eu. Value in Health, 18(7), A649. doi: 10.1016/j.jval.2015.09.2331 Link

Sebestyén, A., Mester, S., Vokó, Z., Gajdácsi, J., Cserháti, P., Speer, G., Patczai, B., Warta, V., Bódis, J., Horváth, C., Boncz, I. (2015). Wintertime surgery increases the risk of conversion to hip arthroplasty after internal fixation of femoral neck fracture. Osteoporosis International, 26(3), 1109-1117. doi: 10.1007/s00198-014-2966-0 Link

Vokó, Z., Beran, D., Pusztai, Zs., Bak Pedersen, H., Evetovits, T., Szigeti, Sz. (2015). Better non-communicable disease outcomes: challenges and opportunities for health systems. Hungary Country Assessment: Focus on diabetes 2014. WHO REGIONAL OFFICE FOR EUROPE. Link

 

2014

Adany, R., Voko, Z. (2014). Hungarian public health - ups and downs in the last 20 years. The European Journal of Public Health, 24(3), 352-353. doi: 10.1093/eurpub/cku034 Link

Ágh, T., Pawaskar, M., Kovacs, G., Kalo, Z., Supina, D., Voko, Z. (2014). The humanistic and economic burden of bulimia nervosa and binge eating disorder: A systematic literature review. Value in Health, 17(3), A213. doi: 10.1016/j.jval.2014.03.1249 Link

Elsisi, G. H., Eldessouki, R., Kalo, Z., Elmazar, M. M., Taha, A. S., Awad, B. F., El-Hamamsy, M. H. (2014). Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model. Value in Health Regional Issues, 4, 24-30. doi: 10.1016/j.vhri.2014.06.004 Link

Gregory, V., Barbeau, M., Machnicki, G., Voko, Z., Heisel, O., Keown, P. (2014). Real world research in Latin America: Opportunities, sources and barriers. Value in Health, 17(3), A188. doi: 10.1016/j.jval.2014.03.1099 Link

Inotai, A., Abonyi-Tóth, Z., Rokszin, G., Voko, Z. (2014). Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary. Value in Health, 17(7), A553. doi: 10.1016/j.jval.2014.08.1809 Link

Inotai, A., Petrova, G., Vitezic, D., Kaló, Z. (2014). Benefits of investment into modern medicines in Central-Eastern European countries. Expert Review of Pharmacoeconomics and Outcomes Research, 14(1), 71-79. doi: 10.1586/14737167.2014.868314 Link

Kaló, Z., Antal, J., Pénzes, M., Pozsgay, C., Szepezdi, Z., Nagyjánosi, L. (2014). Contribution of clinical trials to gross domestic product in Hungary. Croatian Medical Journal, 55(5), 446-451. doi: 10.3325/cmj.2014.55.446 Link

Kalo, Z., Boncz, I., Dank, M., Koczian, K., Molnar, M.J., Nagy, B., Nemeth, Gy., Pitter, J., Zelei, T. (2014). Health Economic Aspects of Personalized Medicine: Do Personalized Technologies Reduce Health Expenditure? [in Hungarian] IME 13. 5. 41-45. Link

Kolasa, K., Kaló, Z., Hornby, E. (2014). Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices. Expert Review of Pharmacoeconomics & Outcomes Research, 15(1), 145-155. doi: 10.1586/14737167.2014.898566 Link

Kovács, G., Kaló, Z., Jahnz-Rozyk, K., Kyncl, J., Csohan, A., Pistol, A., Leleka, M., Kipshakbaev, R., Durand, L., Macabeo, B. (2014). Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother, 10(2), 428-440. doi: 10.4161/hv.26886​ Link

Kwong, D., Ferrario, A., Adamski, J., Inotai, A., Kaló, Z. (2014). Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. EuroHealth, 20(2), 25-28. ​ Link

Lorenzovici, L., Székely, A., Ágh, T., Vámossy, I., Kelemen, L. J., Finta, H., Kaló, Z. (2014). Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania. Value in Health, 17(7), A510. doi: 10.1016/j.jval.2014.08.1563 Link

Meresz, G., Foldesi, Cs., Nagyistok, Sz., Vincziczki, A. (2014). Changes on the market of publications and a dynamising health economic researcher community [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE 2014/2-3, p36-41. Link

Nagy, B., Timár, G., Józwiak-Hagymásy, J., Kovács, G., Merész, G., Vámossy, I., Ágh, T., László, Á., Vokó, Z., Kaló, Z. (2014). The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. European Journal of Obstetrics & Gynecology and Reproductive Biology, 175, 75-81. doi: 10.1016/j.ejogrb.2014.01.022​ Link

Pokhrel, S., Evers, S., Leidl, R., Trapero-Bertran, M., Kalo, Z., Vries, H. d., Crossfield, A., Andrews, F., Rutter, A., Coyle, K., Lester-George, A., West, R., Owen, L., Jones, T., Vogl, M., Radu-Loghin, C., Voko, Z., Huic, M., Coyle, D. (2014). EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open, 4(11), e006945. doi: 10.1136/bmjopen-2014-006945 Link

Sebestyén, A., Mester, S., Vokó, Z., Gajdácsi, J., Cserháti, P., Speer, G., Patczai, B., Warta, V., Bódis, J., Horváth, C., Boncz, I. (2014). Wintertime surgery increases the risk of conversion to hip arthroplasty after internal fixation of femoral neck fracture. Osteoporosis International, 26(3), 1109-1117. doi: 10.1007/s00198-014-2966-0 Link

Strain, W. D., Cos, X., Hirst, M., Vencio, S., Mohan, V., Vokó, Z., Yabe, D., Blüher, M., Paldánius, P. M. (2014). Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 105(3), 302-312. doi: 10.1016/j.diabres.2014.05.005 Link

Vokó, Z., Németh, R., Nagyjánosi, L., Jermendy, G., Winkler, G., Hídvégi, T., Kalotai, Z., Kaló, Z. (2014). Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes. Value in Health Regional Issues, 4, 31-36. doi: 10.1016/j.vhri.2014.06.002 Link

Vokó, Z., Beran, D., Pusztai, Z., Bak Pedersen, H., Evetovits, T., Szigeti, S. (2014). Better non-communicable disease outcomes: challenges and opportunities for health systems. Hungary Country Assessment: Focus on diabetes. Link

Zsólyom, A., Nagy, B., Dessewffy, Z., Steiner, T., Kaló, Z., Vokó, Z. (2014). Cost-effectiveness of the introduction of a risk stratified population screening for type 2 diabetes in hungary. Value in Health, 17(3), A259. doi: 10.1016/j.jval.2014.03.1509 Link

Zsólyom, A., Nagy, B., Nagyjánosi, L., Dessewffy, Z., Steiner, T., Kaló, Z., Vokó, Z. (2014). Cost-Effectiveness of The introduction of A National Adherence Program for Type 2 Diabetes In Hungary. Value in Health, 17(7), A358. doi: 10.1016/j.jval.2014.08.770 Link

 

2013

Agh, T., Meszaros, A., Bartfai, Z. (2013). Quality of life and adherence in chronic obstructive pulmonary disease [in Hungarian]. MEDICAONLINE Link

Boncz, I., Kaló, Z., Mohamed Ibrahim, M. I. B., Greenberg, D. (2013). Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa. Value in Health Regional Issues, 2(2), 169-170. doi: 10.1016/j.vhri.2013.07.007 Link

Elsisi, G. H., Kaló, Z., Eldessouki, R., Elmahdawy, M. D., Saad, A., Ragab, S., Elshalakani, A. M., Abaza, S. (2013). Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt. Value in Health Regional Issues, 2(2), 319-327. doi: 10.1016/j.vhri.2013.06.014 Link

Merész, G., Németh, B., Sinkovits, B. (2013). Conference report. Acta Oeconomica, 63(3), 377-381. doi: 10.1556/aoecon.63.2013.3.7 Link

Kaló, Z., Annemans, L., Garrison, L. P. (2013). Differential pricing of new pharmaceuticals in lower income European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 13(6), 735-741. doi: 10.1586/14737167.2013.847367 Link

Kaló, Z., Bodrogi, J., Boncz, I., Dózsa, C., Jóna, G., Kövi, R., Pásztélyi, Z., Sinkovits, B. (2013). Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary. Value in Health Regional Issues, 2(2), 264-266. doi: 10.1016/j.vhri.2013.06.002 Link

Orosz, E., Meresz, G., Nagy, B. (2013). Investment to human capital: fallback from the developed countries? [in Hungarian] EDUCATIO. Volume 22, Number 2, 2013., p159-176. Link

Szabó, L., Jackowska, T., Kaló, Z., Kulcsár, A., Mészner, Z., Molnár, Z., Wysocki, J., Wutzler, P., Kormos-Tasi, J., Sauboin, C. (2013). Varicella vaccination in Hungary and Poland: optimization of public benefits from prophylaxis technologies in the time of austerity. New Medicine.  Link

Szabó, R. P., Klenk, N., Balla, J., Asztalos, L., Szabó, L., Vokó, Z. (2013). Prognosis of Dialysed Patients after Kidney Transplant Failure. Kidney and Blood Pressure Research, 37(2-3), 151-157. doi: 10.1159/000350140 Link

Voko, Z., Inotai, A., Horvath, Cs., Bors, K., Speer, G., Kalo, Z. (2013). Quality of Life of Patients With Osteoporosis In Hungary. [in Hungarian] Lege Artis Medicinae 3(4). Link

Voko, Z., Nemeth, R., Dank, M., Nagy-Erdei, Z., Kalo, Z., Geczi, L. (2013). Mapping the Cancer-Specific EORTC QLQ-BR23 onto the Preference-Based EuroQol-5D Instrument. Journal of Health Policy and Outcomes Research(2), 90-99. doi: 10.7365/JHPOR.2013.4.10 Link

Zsólyom, A., Merész, G., Nagyjánosi, L., Nagyistók, S., Nagy, B., Kaló, Z., Vokó, Z. (2013). External Validation of the Syreon Diabetes Model. Value in Health, 16(7), A590. doi: 10.1016/j.jval.2013.08.1640 Link

 

2012

Borsos, G., Vokó, Z., Gredes, T., Kunert-Keil, C., Vegh, A. (2012). Tooth movement using palatal implant supported anchorage compared to conventional dental anchorage. Annals of Anatomy - Anatomischer Anzeiger, 194(6), 556-560. doi: 10.1016/j.aanat.2012.08.003 Link

Inotai, A., Agh, T., Meszaros, A. (2012). Quality of life, utility and health burden in asthma, chronic obstructive pulmonary disease and rheumatoid arthritis. International Journal of Person Centered Medicine, 2(3), 505-510. doi: 10.5750/ijpcm.v2i3.254 Link

Inotai, A., Kalo, Z. (2012). Risk sharing methods in middle income countries [in Hungarian]. ACTA PHARMACEUTICA HUNGARICA 82: 43-52. Link

Inotai, A., Meszaros, A. (2012). Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study. Acta poloniae pharmaceutica, 69(4), 773-777. Link

Inotai, A., Nagy, B., Kalo, Z. (2012). Biosimilars and evidence based decision making in Central Eastern European countries. [in Hungarian] ORVOSTOVABBKEPZO SZEMLE 19: 69-73. Link

Inotai, A., Nuijten, M., Roth, E., Hegazi, R., Kaló, Z. (2012). Modelling the burden of disease associated malnutrition. e-SPEN Journal, 7(5), e196-e204. doi: 10.1016/j.clnme.2012.07.003 Link

Inotai, A., Pékli, M., Jóna, G., Nagy, O., Remák, E., Kaló, Z. (2012). Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Services Research, 12(1). doi: 10.1186/1472-6963-12-332 Link

Kalo, Z., Abonyi-Toth, Z., Bartfai, Z., Voko, Z. (2012). Pitfalls associated with the therapeutic reference pricing practice of asthma medication. BMC Pulmonary Medicine, 12(1). doi: 10.1186/1471-2466-12-35 Link

Kaló, Z., Boncz, I., Inotai, A. (2012). Implications of economic crisis on health care decision-making in Hungary: An opportunity to change. Journal of Health Policy and Outcomes Research, 1, 20-26.  Link

Kaló, Z., Landa, K., Doležal, T., Vokó, Z. (2012). Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. European Journal of Cancer Care, 21(4), 442-449. doi: 10.1111/j.1365-2354.2012.01351.x Link

Kalo, Z., Meresz, G., Mezei, D., Totth, A., Inotai, A. (2012). The grounding and implications of Szell Kalman Plan [in Hungarian]. IME AZ EGESZSEGUGYI VEZETOK SZAKLAPJA 11:6 12-16. Link

Kalo, Z., Nagy, B. (2012). Methodological questions in assessing the cost effectiveness of prevention programs. [in Hungarian] EGESZSEGUGYI GAZDASAGI SZEMLE 50:1 29-31. Link

Kolasa, K., Kalo, Z., Zah, V., Doležal, T. (2012). Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 12(3), 283-287. doi: 10.1586/erp.12.12 Link

Meresz, G., Tabak, A., Kalo, Z. (2012). Cost minimisation analysis of basal insulin analogues for treatment of type 2 diabetes. [in Hungarian] LEGE ARTIS MEDICINAE 22(12):669–676. Link

Meszaros, A., Agh, T., Bartfai, Z., Orosz, M. (2012). Quality of life decrement and health burden in asthma and COPD [in Hungarian]. MEDICINA THORACALIS  65: 219.

Nagy, B., Gaspar, I., Papp, A., Bene, Z., Nagy, B., Voko, Z., Balla, G. (2012). Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology, 48(2), 168-175. doi: 10.1002/ppul.22574 Link

Nagy, B., Meresz, G. (2012). Role of risk-sharing in health care. [in Hungarian] EGESZSEGUGYI GAZDASAGI SZEMLE November 1; 50(4): 42-48. Link

Nagy, B., Nagyjanosi, L., Nagyistok, Sz., Jozwiak-Hagymasy, J., Meresz, G., Papp, E., Dessewffy, Z., Jermendy, Gy., Winkler, G., Kalo, Z., Voko, Z. (2012). Health economic model to assess the screening, treatment and management strategies of diabetes. [in Hungarian] DIABETOLOGIA HUNGARICA 20.4 p.245-255. Link

Papp, K., Végh, P., Hóbor, R., Szittner, Z., Vokó, Z., Podani, J., Czirják, L., Prechl, J. (2012). Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays. PLoS ONE, 7(9), e44824. doi: 10.1371/journal.pone.0044824 Link

Petrovski, B. É., Pataki, V., Jenei, T., Ádány, R., Vokó, Z. (2012). Selenium levels in men with liver disease in Hungary. Journal of Trace Elements in Medicine and Biology, 26(1), 31-35. doi: 10.1016/j.jtemb.2012.01.001 Link

Szigethy, E., Széles, G., Horváth, A., Hidvégi, T., Jermendy, G., Paragh, G., Blaskó, G., Ádány, R., Vokó, Z. (2012). Epidemiology of the metabolic syndrome in Hungary. Public Health, 126(2), 143-149. doi: 10.1016/j.puhe.2011.11.003 Link

Vokó, Z., Kaló, Z. (2012). Prevenció - kiadások – hatékonyság, Egészségügyi Gazdasági Szemle, 2012. 50. 1. 6-8. Link

Vokó, Z., Nagyjánosi, L., Kaló, Z. (2012). Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary. BMC Public Health, 12(1). doi: 10.1186/1471-2458-12-924 Link

Vokó, Z., Nagyjánosi, L., Margitai, B., Kövi, R., Tóth, Z., László, D., Kaló, Z. (2012). Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary. Value in Health, 15(1), 39-45. doi: 10.1016/j.jval.2011.10.003 Link

Walter, S., Mackenbach, J., Vokó, Z., Lhachimi, S., Ikram, M. A., Uitterlinden, A. G., Newman, A. B., Murabito, J. M., Garcia, M. E., Gudnason, V., Tanaka, T., Tranah, G. J., Wallaschofski, H., Kocher, T., Launer, L. J., Franceschini, N., Schipper, M., Hofman, A., Tiemeier, H. (2012). Genetic, Physiological, and Lifestyle Predictors of Mortality in the General Population. American Journal of Public Health, 102(4), e3-e10. doi: 10.2105/ajph.2011.300596 Link

 

2011

Agh, T., Inotai, A., Meszaros, A. (2011). Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease. Respiration, 82(4), 328-334. doi: 10.1159/000324453​ Link

Barkai, L., Blatniczky, L., Halmos, T., Hidvégi, T., Jermendy, Gy., Kaló, Z., Madácsy, L., Vándorfi, Gy., Winkler, G., Wittmann, I. (2011). Nemzeti Diabetesprogram. Diabetologia Hungarica, 2011. 19. 3. Supplementum 5-39. Link

Gorog, K., Pattenden, S., Antova, T., Niciu, E., Rudnai, P., Scholtens, S., Splichalova, A., Slotova, K., Vokó, Z., Zlotkowska, R., Houthuijs, D. (2011). Maternal smoking during pregnancy and childhood obesity: results from the CESAR Study. Maternal & Child Health Journal, 15(7), 985-992. doi: 10.1007/s10995-009-0543-5 Link

Inotai, A., Meresz, G., Kalo, Z. (2011). Assessment of Hungarian pharmaceutical expenditures with respect to Szell Kalman Plan [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE 49: 9-13. Link

Inotai, A., Rojkovich, B., Fülöp, A., Jászay, E., Ágh, T., Mészáros, Á. (2011). Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatology International, 32(4), 963-969. doi: 10.1007/s00296-010-1721-x Link

Kaló, Z., Jermendy, Gy., Winkler, G., Hidvégi, T., Borsi, A., Novákné Pékli, M., Kincses, J., Kalotai, Z., Vokó, Z. (2011). A cukorbetegség társadalmi terhe és egészségügyi prioritásának indoka. Diabetologia Hungarica, 2011. 19. 3. 245–251. Link

Kaló, Z., Vokó, Z. (2011). Health technology assessment: a European collaboration. Expert Review of Pharmacoeconomics & Outcomes Research, 11(1), 41-43. doi: 10.1586/erp.10.90 Link

Losonczy, G., Fekete, Á., Vokó, Z., Takács, L., Káldi, I., Ajzner, É., Kasza, M., Vajas, A., Berta, A., Balogh, I. (2011). Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients. Acta Ophthalmologica, 89(3), 255-262. doi: 10.1111/j.1755-3768.2009.01687.x Link

Meszaros, A., Szabo, L., Agh, T., Fujsz, E., Bartfai, Z. (2011). Measurement of health related quality of life and asthma control in Hungary [in Hungarian]. TUDOGYOGYASZAT 5: 28-31.

Nagy, B., Brennan, A., Brandtmüller, A., Thomas, S. K., Sullivan, S. D., Akehurst, R. (2011). Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models. International Journal of Geriatric Psychiatry, 26(5), 483-494. doi: 10.1002/gps.2551 Link

Nagy, B., Nagyjanosi, L., Nagyistok, S., Józwiak-Hagymásy, J., Dessewffy, Z., Kalo, Z., Vokó, Z. (2011). PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes. Value in Health, 14(7), A486-A487. doi: 10.1016/j.jval.2011.08.1385 Link

Nagyjanosi, L., Martos, É., Bödönyi, D., Vokó, Z. (2011). PCV67 Health-Economic Impact of the Hungarian Salt Intake Reduction Program. Value in Health, 14(7), A376. doi: 10.1016/j.jval.2011.08.787 Link

Németh, J., Nagyjánosi, L., Nagyistók, Sz., Tolnayné Csattos, M., Szabóné Berta, I., Kincse, É., Szulyák, E., Boér, I., Hundzsa, Gy., Kaló, Z., Berta, A. (2011). Időskori vakság betegségterhe Magyarországon. Lege Artis Medicinae 2011. 21. 10. 641–647. Link

Ohmann, C., Kuchinke, W., Canham, S., Lauritsen, J., Salas, N., Schade-Brittinger, C., Wittenberg, M., McPherson, G., McCourt, J., Gueyffier, F., Lorimer, A., Torres, F. (2011). Standard requirements for GCP-compliant data management in multinational clinical trials. Trials, 12(1). doi: 10.1186/1745-6215-12-85 Link

Papp, K., Végh, P., Hóbor, R., Szittner, Z., Vokó, Z., Podani, J., Korányi, K. L., Czirják, L. K., Prechl, J. (2011). Functional serum antibody profiles in autoimmune disease diagnostics. Molecular Immunology, 48(14), 1732. doi: 10.1016/j.molimm.2011.06.432 Link

Petrovski, B. É., Széles, G., Melles, M., Pataki, V., Kardos, L., Jenei, T., Ádány, R., Vokó, Z. (2011). Behaviour does not fully explain the high risk of chronic liver disease in less educated men in Hungary. European Journal of Public Health, 21(5), 662-666. doi: 10.1093/eurpub/ckq079 Link

Rojkovich, B., Inotai, A. (2011). Cardiovascular safety of nonsteroidal antiinflammatory drugs [in Hungarian]. LEGE ARTIS MEDICINAE 21: 123-125. Link

Szabo, R.P., Asztalos, L., Szabo, L., Balla, J., Vokó, Z. (2011). Validation of a prognostic function for renal transplant recipients in Hungary. Journal of Nephrology 24:(5) pp. 619-624. doi: 10.5301/JN.2011.8354 Link

Vokó, Z., de Brouwer, S., Lubsen, J., Danchin, N., Otterstad, J.-E., Dunselman, P. H. J. M., Kirwan, B.-A. (2011). Long-term impact of secondary preventive treatments in patients with stable angina. European Journal of Epidemiology, 26(5), 375-383. doi: 10.1007/s10654-011-9558-5 Link

 

2010

Ágh, T., Mészáros, Á. (2010). Compliance and persistence with medications for chronic obstructive pulmonary disease. Clinical and Experimental Medical Journal, 4(1), 15-22. doi: 10.1556/cemed.4.2010.28691 Link

Agh, T., Bartfai, Z., Meszaros, A. (2010). Relation of adherence to quality of life in COPD patients. [in Hungarian]. MEDICINA THORACALIS  63: 197

Agh, T., Bodnar, R., Agh, L. (2010). The importance of quality of life monitoring in the management of asthma [in Hungarian]. MEDICUS UNIVERSALIS 43: 179-181.

Agh, T., Meszaros, A. (2010). Pharmacoeconomic impact of compliance [in Hungarian]. ACTA PHARMACEUTICA HUNGARICA 80: 75-80. Link

Antal, J., Szepezdi, Zs., Nagyjánosi, L., Kaló, Z. (2010). A nemzetközi klinikai vizsgálatok helyzete és hozadéka Magyarországon. IME, 2010. 10. 1. 5-10. Link

Bodrogi, J., Kaló, Z. (2010). Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. British Journal of Pharmacology, 159(7), 1367-1373. doi: 10.1111/j.1476-5381.2009.00550.x Link

Inotai, A., Hankó, B., Mészáros, Á. (2010). Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information. Pharmacoepidemiology and Drug Safety, 19(2), 183-190. doi: 10.1002/pds.1893 Link

Inotai, A., Kalo, Z. (2010). The assessment of innovation and the R&D&I strategy of public health care sector [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE  48: 33-38.

Inotai, A., Meresz, G., Kalo, Z. (2010). Assessment of the pharmaceutical expenditure in Hungary [in Hugarian]. ACTA PHARMACEUTICA HUNGARICA 80: 162-172. Link

Inotai, A., Rojkovich, B., Meszaros, A. (2010). The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary-a cross sectional non interventional study. [in Hungarian] ACTA PHARMACEUTICA HUNGARICA 80: 47-54. Link

Kaló, Z., Józwiak-Hagymásy, J., Németh, A. (2010). A napi adagolás, mint a beteg-együttműködést befolyásoló tényező –vizsgálata szkizofréniában szenvedő betegek körében. IME, 2010. 9. 5. 37-42. Link

Kalo, Z., Kiss, Z., Gerendy, P., Nagyjanosi, L., Voko, Z. (2010). COST OF RENAL REPLACEMENT THERAPY IN HUNGARY. Transplantation Journal, 90, 735. doi: 10.1097/00007890-201007272-01416 Link

Kaló, Z., Kovács, A., Margitai, B., Mészner, Zs., Vokó, Z. (2010). „Value of vaccine – A védőoltás érték” program Fehér Könyve. IME, 2010. 10. 1. 39-44. Link

Kaló, Z., Vokó, Z. (2010). A kockázatmegosztás szerepe a gyógyszerek finanszírozásában. Lege Artis Medicinae 2010. 20. 3-4. 237-241 Link

Kuchinke, W., Ohmann, C., Yang, Q., Salas, N., Lauritsen, J., Gueyffier, F., Leizorovicz, A., Schade-Brittinger, C., Wittenberg, M., Voko, Z., Gaynor, S., Cooney, M., Doran, P., Maggioni, A., Lorimer, A., Torres, F., McPherson, G., Charwill, J., Hellström, M., Lejeune, S. (2010). Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres. Trials, 11(1). doi: 10.1186/1745-6215-11-79 Link

Nagy, B. (2010). Resource allocation in Hungarian health care - Is there a missing link? [in Hungarian]. KOZGAZDASAGI SZEMLE 57:4 337-353. Link

Orosz, M., Galffy, G., Agh, T., Kovacs, D., Meszaros, A. (2010). The everyday life of patients with asthma or COPD. [in Hungarian]. MEDICINA THORACALIS 63: 181-182.

Vokó, Z., Danchin, N., de Brouwer, S., Kirwan, B.-A., Poole-Wilson, P. A., Lubsen, J. (2010). Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: The ACTION experience. International Journal of Cardiology, 138(1), 56-62. doi: 10.1016/j.ijcard.2008.08.036 Link

Vokó, Z., Nagyjánosi, L., Kaló, Z. (2010) Cost-effectiveness analysis of adding HPV vaccination to cervical cancer screening program in Hungary. Value in Health, 13:(7) pp. A270-A271. Link

 

2009

Agh, T., Agh, L. (2009). The significance of medication compliance and persistence in hypertension, diabetes mellitus and dyslipidemia [in Hungarian]. MEDICUS UNIVERSALIS  42: 3-6. (2009)

Agh, T., Meszaros, A. (2009). Compliance and persistence with medication in chronic obstructive pulmonary disease [in Hungarian]. ORVOSI HETILAP 150: 1497-1502. doi: 10.1556/OH.2009.28691 Link

Inotai, A., Kalo, Z., Meszaros, A. (2009). Decision analytic modeling and their impact on health care decision making. [in Hungarian] ACTA PHARMACEUTICA HUNGARICA 79: 63-69. Link

Inotai, A., Mészáros, Á. (2009). Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis. International Journal of Technology Assessment in Health Care, 25(02), 190-195. doi: 10.1017/s0266462309090242 Link

Kaló, Z. (2009). Az egészség-gazdaságtani elemzések és az objektív támogatáspolitikai rendszer dilemmái Magyarországon. Lege Artis Medicinae, 2009. 19. 4–5. 329–333. Link

Kaló, Z., Bors, K., Dank, M., Géczi, L., Horváth, Cs., Jermendy, Gy., Kalotai, Z., Kincses, J., Margitai, B., Novákné Pékli, M., Vasvári, A., Thurzó, L., Vokó, Z., Winkler, G., Zalatnainé Tóth, K. (2009). Együtt az egészségért: az életminőség mérésének jelentősége a bizonyítékokon alapuló egészségpolitikai döntéshozatalban. Orvostovábbképző Szemle. 2009. 16. 9. 12-14.

Marton, I., Masszi, T., Kaló, Z. (2009). A Transzparencia Direktíva implementálásának kérdései a deferazirox ártámogatása kapcsán. IME, 2009. 8. 1. 40-44. Link

Nagy, B., Brandtmuller, A., Dozsa, Cs. (2009). The Redistributive Role of the State in the British and Dutch Health Care Market. Is there another Way? [in Hungarian] TARSADALOMKUTATAS (SOCIAL SCIENCE RESEARCH) 27: 2117-2138. Link

Nagy, B., Brennan, A., Skultety, L., Nagy, J., Szentesi, A., Dessewffy, Z., Kalotai , Z. (2009). The cost effectiveness of rivastigmine transdermal patch in the management of patients with mild and moderate Alzheimer’s disease [in Hungarian]. IME 8:3 40-45. Link

Voko, Z., Csepe, P., Nemeth, R., Kosa, K., Kosa, Z., Szeles, G., Adany, R. (2009). Does socioeconomic status fully mediate the effect of ethnicity on the health of Roma people in Hungary? Journal of Epidemiology & Community Health, 63(6), 455-460. doi: 10.1136/jech.2008.079715 Link

Voko, Z., Nagyjanosi, L., Kalo, Z. (2009). Direct health care costs of diabetes mellitus in Hungary [in Hungarian], LEGE ARTIS MEDICIANE 19(12):775-780. Link

 

2008

Bhalla, A., Grieve, R., Rudd, A. G., Wolfe, C. D. A. (2008). Stroke in the Young: Access to Care and Outcome; A Western Versus Eastern European Perspective. Journal of Stroke and Cerebrovascular Diseases, 17(6), 360-365. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.002 Link

Inotai, A., Meszaros, A. (2008). Cost effectiveness of celecoxib in rheumatoid arthritis [in Hungarian], IME 7: 48-50. Link

Inotai, A., Vincze, Z. (2008). Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols [in Hungarian], ACTA PHARMACEUTICA HUNGARICA 78: 79-86. Link

Kaló, Z., Nagy, B. (2008). Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében – Hogyan mérjük egy védőoltás költséghatékonyságát? IME, 2008. 7. 8. 42-45. Link

Nagy, B., Brandtmüller, Á. (2008). Implementing Risk Adjusted Capitation Payments with Health Care Reforms in Hungary. Competitio, 7(2), 147-160. doi:10.21845/comp/2008/2/8 Link

Nagy, B., Kaló, Z., Hegyi, R. (2008) Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében III. IME, 2008. 7. 10. 24-29. Link

Nagy, B., Kaló, Z. (2008). Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében - Egészséges társadalom és gazdasági növekedés: ok és okozat? IME, 2008. 7. 7. 37-40. Link

Nagy, B., Rakonczai, P., Gulacsi, L. (2008) Application of statistical methods to calculate capitation payments in the Hungarian health care. [in Hungarian] STATISZTIKAI SZEMLE (HUNGARIAN STATISTICAL REVIEW) 86:4 321-341. Link

Nagy, B., Rakonczai, P., Sipos, J. (2008). Predicting health care expenditures with demographic characteristics for designing capitation payments in Hungary [in Hungarian]. IME  7:Egeszseg-gazdasagtani kulonszam 5-9. Link

Takemoto, S. K., Arns, W., Bunnapradist, S., Garrison, L. P., Guirado, L., Kalo, Z., Oniscu, G., Opelz, G., Scolari, M. P., Stefoni, S., Yaqoob, M., Brennan, D. C. (2008). Expanding the Evidence Base in Transplantation: The Complementary Roles of Randomized Controlled Trials and Outcomes Research. Transplantation, 86(1), 18-25. doi: 10.1097/tp.0b013e31817d4df5 Link